
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            High-throughput functional evaluation of BRCA2 variants of unknown significance - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B3BCC9264EF333C3BCC00001A9CF7.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ncomms">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nature Communications">
<meta name="citation_title" content="High-throughput functional evaluation of BRCA2 variants of unknown significance">
<meta name="citation_author" content="Masachika Ikegami">
<meta name="citation_author_institution" content="Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan">
<meta name="citation_author_institution" content="Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan">
<meta name="citation_author" content="Shinji Kohsaka">
<meta name="citation_author_institution" content="Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan">
<meta name="citation_author" content="Toshihide Ueno">
<meta name="citation_author_institution" content="Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan">
<meta name="citation_author" content="Yukihide Momozawa">
<meta name="citation_author_institution" content="Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Kanagawa, 230-0045 Japan">
<meta name="citation_author" content="Satoshi Inoue">
<meta name="citation_author_institution" content="Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan">
<meta name="citation_author_institution" content="Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan">
<meta name="citation_author" content="Kenji Tamura">
<meta name="citation_author_institution" content="Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045 Japan">
<meta name="citation_author" content="Akihiko Shimomura">
<meta name="citation_author_institution" content="Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045 Japan">
<meta name="citation_author" content="Noriko Hosoya">
<meta name="citation_author_institution" content="Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan">
<meta name="citation_author_institution" content="Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan">
<meta name="citation_author" content="Hiroshi Kobayashi">
<meta name="citation_author_institution" content="Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan">
<meta name="citation_author" content="Sakae Tanaka">
<meta name="citation_author_institution" content="Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan">
<meta name="citation_author" content="Hiroyuki Mano">
<meta name="citation_author_institution" content="Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan">
<meta name="citation_publication_date" content="2020 May 22">
<meta name="citation_volume" content="11">
<meta name="citation_firstpage" content="2573">
<meta name="citation_doi" content="10.1038/s41467-020-16141-8">
<meta name="citation_pmid" content="32444794">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/pdf/41467_2020_Article_16141.pdf">
<meta name="description" content="Numerous nontruncating missense variants of the BRCA2 gene have been identified, but there is a lack of convincing evidence, such as familial data, demonstrating their clinical relevance and they thus remain unactionable. To assess the pathogenicity ...">
<meta name="og:title" content="High-throughput functional evaluation of BRCA2 variants of unknown significance">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Numerous nontruncating missense variants of the BRCA2 gene have been identified, but there is a lack of convincing evidence, such as familial data, demonstrating their clinical relevance and they thus remain unactionable. To assess the pathogenicity ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="7244490">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41467-020-16141-8"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41467_2020_Article_16141.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7244490%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/7244490/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/7244490/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ncomms.gif" alt="Nature Communications logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Nature Communications" title="Link to Nature Communications" shape="default" href="http://www.nature.com/ncomms/index.html" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Nat Commun</button></div>. 2020 May 22;11:2573. doi: <a href="https://doi.org/10.1038/s41467-020-16141-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41467-020-16141-8</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Nat%20Commun%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nat%20Commun%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Nat%20Commun%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Nat%20Commun%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>High-throughput functional evaluation of <em>BRCA2</em> variants of unknown significance</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ikegami%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Masachika Ikegami</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Masachika Ikegami</span></h3>
<div class="p">
<sup>1</sup>Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan </div>
<div class="p">
<sup>2</sup>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ikegami%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Masachika Ikegami</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kohsaka%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Shinji Kohsaka</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Shinji Kohsaka</span></h3>
<div class="p">
<sup>1</sup>Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kohsaka%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shinji Kohsaka</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ueno%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Toshihide Ueno</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Toshihide Ueno</span></h3>
<div class="p">
<sup>1</sup>Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ueno%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Toshihide Ueno</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Momozawa%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yukihide Momozawa</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yukihide Momozawa</span></h3>
<div class="p">
<sup>3</sup>Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Kanagawa, 230-0045 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Momozawa%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yukihide Momozawa</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Inoue%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Satoshi Inoue</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Satoshi Inoue</span></h3>
<div class="p">
<sup>1</sup>Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan </div>
<div class="p">
<sup>4</sup>Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Inoue%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Satoshi Inoue</span></a>
</div>
</div>
<sup>1,</sup><sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tamura%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Kenji Tamura</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Kenji Tamura</span></h3>
<div class="p">
<sup>5</sup>Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tamura%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kenji Tamura</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shimomura%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Akihiko Shimomura</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Akihiko Shimomura</span></h3>
<div class="p">
<sup>5</sup>Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shimomura%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Akihiko Shimomura</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hosoya%20N%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Noriko Hosoya</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Noriko Hosoya</span></h3>
<div class="p">
<sup>4</sup>Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="p">
<sup>6</sup>Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hosoya%20N%22%5BAuthor%5D" class="usa-link"><span class="name western">Noriko Hosoya</span></a>
</div>
</div>
<sup>4,</sup><sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Hiroshi Kobayashi</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Hiroshi Kobayashi</span></h3>
<div class="p">
<sup>2</sup>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kobayashi%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hiroshi Kobayashi</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tanaka%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Sakae Tanaka</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Sakae Tanaka</span></h3>
<div class="p">
<sup>2</sup>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Tanaka%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sakae Tanaka</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mano%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Hiroyuki Mano</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Hiroyuki Mano</span></h3>
<div class="p">
<sup>1</sup>Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mano%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hiroyuki Mano</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Division of Cellular Signaling, National Cancer Center Research Institute, Tokyo, 104-0045 Japan </div>
<div id="Aff2">
<sup>2</sup>Department of Orthopaedic Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div id="Aff3">
<sup>3</sup>Laboratory for Genotyping Development, RIKEN Center for Integrative Medical Sciences, Kanagawa, 230-0045 Japan </div>
<div id="Aff4">
<sup>4</sup>Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div id="Aff5">
<sup>5</sup>Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, 104-0045 Japan </div>
<div id="Aff6">
<sup>6</sup>Laboratory of Molecular Radiology, Center for Disease Biology and Integrative Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 Japan </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2019 Jun 27; Accepted 2020 Apr 17; Collection date 2020.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2020</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit <a href="http://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC7244490  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32444794/" class="usa-link">32444794</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par1">Numerous nontruncating missense variants of the <em>BRCA2</em> gene have been identified, but there is a lack of convincing evidence, such as familial data, demonstrating their clinical relevance and they thus remain unactionable. To assess the pathogenicity of variants of unknown significance (VUSs) within <em>BRCA2</em>, here we develop a method, the MANO-B method, for high-throughput functional evaluation utilizing <em>BRCA2</em>-deficient cells and poly (ADP-ribose) polymerase (PARP) inhibitors. The estimated sensitivity and specificity of this assay compared to those of the International Agency for Research on Cancer classification system is 95% and 95% (95% confidence intervals: 77–100% and 82–99%), respectively. We classify the functional impact of 186 <em>BRCA2</em> VUSs with our computational pipeline, resulting in the classification of 126 variants as normal/likely normal, 23 as intermediate, and 37 as abnormal/likely abnormal. We further describe a simplified, on-demand annotation system that could be used as a companion diagnostic for PARP inhibitors in patients with unknown <em>BRCA2</em> VUSs.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Subject terms:</strong> Breast cancer, Cancer genomics, Ovarian cancer</p></section></section><section class="abstract" id="Abs2"><hr class="headless">
<p id="Par2">Many germline variants are found in the <em>BRCA2</em> gene, some of which pre-dispose women to breast and ovarian cancer. Here, the authors develop a method to determine the functional significance of <em>BRCA2</em> variants and show that it is comparable to the IARC system of classifying variants.</p></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par3">The <em>BRCA1</em> and <em>BRCA2</em> (<em>BRCA</em>) genes encode key proteins in the homology-directed DNA break repair (HDR) pathway, and their inactivation predisposes individuals to cancer development<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Germline loss-of-function variants in <em>BRCA</em> markedly increase the risk of early-onset breast and ovarian cancer; in such cases, prophylactic oophorectomy and mastectomy and genetic testing for at-risk relatives must be considered<sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. Tumors with pathogenic variants within <em>BRCA</em> and defective HDR have been shown to be particularly sensitive to platinum-based chemotherapies and poly (ADP-ribose) polymerase (PARP) inhibitors, the efficacy of which is mediated through synthetic lethality in cancer cells with <em>BRCA</em> loss-of-function<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a></sup>.</p>
<p id="Par4">The American College of Medical Genetics and Genomics (ACMG) standards and guidelines for the interpretation of sequence variants recommend a process for variant classification based on criteria using population, computational, functional, and segregation data<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. The ACMG guidelines assign a categorical strength to each evidence: supporting, moderate, strong, very strong, or stand-alone. Then, each variant is assigned to five categories using combining criteria: benign, likely benign, uncertain significance, likely pathogenic, and pathogenic. Family-based studies including a multifactorial model of pathology, a cosegregation profile, and the cooccurrence and family history of cancer may exemplify the most reliable methods for classifying <em>BRCA2</em> gene variants<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>,<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. Nonsense or frameshift variants within the coding exons of <em>BRCA</em> markedly alter the structures of the protein products and are presumed to confer loss-of-function. However, the vast majority of missense variants are individually rare in both general populations and cancer patients, and case–control studies may not have sufficient statistical significance to classify these variants as pathogenic or benign<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>–<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. No current in silico computational prediction algorithm for missense variants is accurate enough when used alone<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. In the framework of the ACMG guidelines, the functional impact of a variant, which is determined by a well-established functional assay, is regarded as strong evidence for benign/pathogenic status<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>. Thus, the functional evaluation of missense variants of unknown significance (VUSs) is urgently required to improve the interpretation of variants identified by genetic testing and to support clinical decision-making for their carriers<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>.</p>
<p id="Par5">While thousands of <em>BRCA1</em> VUSs have been assessed by recently developed high-throughput functional assays<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>, a few hundred <em>BRCA2</em> variants have been evaluated by a conventional functional assay for <em>BRCA2</em>, the HDR assay<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. The HDR assay has three issues requiring improvement: (i) the throughput is quite low, (ii) it uses a hamster cell line with transient expression of <em>BRCA2</em> cDNA, and most importantly, (iii) it can evaluate only variants in the DNA-binding domain<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>,<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. To overcome these limitations, we propose herein a high-throughput method using a human cell line stably expressing <em>BRCA2</em> variants that enables the evaluation of all exonic variants of the <em>BRCA2</em> gene.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Stable transduction of <em>BRCA2</em> variants</h3>
<p id="Par6">The introduction and stable expression of <em>BRCA2</em> variants in human cells is technically difficult owing to the relatively large coding sequence of this gene (10.2 kbp)<sup><a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>. We addressed this issue by employing a piggyBac transposon vector suitable for the stable introduction of large DNA sequences into the genome<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. In addition, we utilized a <em>BRCA2</em> knockout human colorectal adenocarcinoma cell line, DLD1 <em>BRCA2</em> (−/−), which is known to be highly sensitive to PARP inhibition compared to parental cells retaining <em>BRCA2</em><sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>,<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. If a <em>BRCA2</em> missense variant is further introduced into DLD1 <em>BRCA2</em> (−/−) cells, the change in PARP inhibitor sensitivity likely reflects the function of the introduced variant. For instance, the expression of a functionally normal variant in DLD1 <em>BRCA2</em> (−/−) cells should restore HDR and thus resistance to PARP inhibitors.</p>
<p id="Par7">Initially, a total of 107 <em>BRCA2</em> variants were selected from a curated database, the BRCA Exchange<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup> (Supplementary Data <a href="#MOESM4" class="usa-link">1</a>). Of these, 32, 10, and 65 variants were classified as benign (Class 1/2), pathogenic (Class 4/5), and VUSs (Class 3), respectively, according to the multifactorial five-tier classification system developed by the International Agency for Research on Cancer (IARC)<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>,<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>,<a href="#CR27" class="usa-link" aria-describedby="CR27">27</a></sup>. The IARC classification is based on epidemiological data and does not utilize functional evidence. These <em>BRCA2</em> variant cDNAs were generated by site-directed mutagenesis and were then subcloned into the piggyBac vector containing unique 10 bp DNA barcode sequences. These individual piggyBac plasmids, together with the hyPBase transposase expression vector, were transfected into DLD1 <em>BRCA2</em> (−/−) cells<sup><a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>.</p>
<p id="Par8">The transduction efficiency for 20 selected variants was evaluated by real-time quantitative reverse transcription PCR (qRT-PCR) and digital droplet PCR (Supplementary Fig. <a href="#MOESM1" class="usa-link">1a, b</a>). The mRNA expression levels were within the physiological range of endogenous <em>BRCA2</em> with no significant difference among the variants, whereas the copy numbers of the integrated <em>BRCA2</em> cDNA were approximately 10. Western blotting demonstrated that the protein expression levels of the 19 BRCA2 variants were generally equal to that of wild-type BRCA2 (Supplementary Fig. <a href="#MOESM1" class="usa-link">1c</a>).</p></section><section id="Sec4"><h3 class="pmc_sec_title">Establishment of MANO-B method</h3>
<p id="Par9">We next performed a cell viability assay to evaluate the drug sensitivity of the <em>BRCA2</em> variants. Cells treated with PARP inhibitors (olaparib, niraparib, and rucaparib) or carboplatin (CBDCA) at various concentrations for 6 days were assessed with PrestoBlue reagent (Supplementary Fig. <a href="#MOESM1" class="usa-link">2</a>). Wild-type <em>BRCA2</em> and benign variants showed greater tolerance to these drugs than pathogenic variants. However, the threshold between the benign and pathogenic variants was unclear. It is important to note that wild-type <em>BRCA2</em>-induced cells were significantly more sensitive than parental DLD1 cells; therefore, we should establish a sensitive method in which all comparisons could be made with wild-type-induced cells rather than parental cells. We thus modified the mixed-all-nominated-in-one (MANO) method<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>,<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup> that was originally developed to enable high-throughput evaluation of VUSs in transforming genes and invented the MANO-<em>BRCA</em> (MANO-B) method for the functional evaluation of <em>BRCA2</em> variants (Fig. <a href="#Fig1" class="usa-link">1</a>).</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1. Schematic representation of the MANO-B method.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7244490_41467_2020_16141_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfb/7244490/fe53bc1f2d10/41467_2020_16141_Fig1_HTML.jpg" loading="lazy" id="d30e615" height="564" width="675" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><em>BRCA2</em> variants of interest were generated by site-directed mutagenesis and subcloned into the piggyBac transposon vector with a unique barcode sequence, followed by sequence verification. DLD1 <em>BRCA2</em> (−/−) cells were individually cotransfected with the <em>BRCA2</em> constructs and transposase expression vector. After puromycin selection of stable transfectants, equal numbers of DLD1 cells were mixed and cultured with PARP inhibitors, CBDCA, or DMSO for 12 days. The barcode sequences were amplified by PCR with genomic DNA extracted from the cell mixture and deep sequenced to quantify their relative abundances. The ratio of each barcode abundance was normalized to that of the DMSO-treated control. The relative viability data were analyzed by Bayesian inference, and the pathogenicity of each variant was then classified.</p></figcaption></figure><p id="Par10">In the MANO-B method, DLD1 <em>BRCA2</em> (−/−) cells were transfected with the individual <em>BRCA2</em> variant cDNAs and the variant-specific barcodes, mixed, and cultured with or without drugs. Genomic DNA was extracted from each cell mixture after the drug treatments, and the barcode sequences were amplified by PCR and deep sequenced. The barcode read count, which was linearly correlated to the number of viable cells harboring the corresponding variant<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a></sup>, was normalized to that of the vehicle control to evaluate the relative cell viability. Based on these profiles, the drug sensitivity and pathogenicity of each variant were determined (Fig. <a href="#Fig1" class="usa-link">1</a>).</p></section><section id="Sec5"><h3 class="pmc_sec_title">MANO-B method for 107 <em>BRCA2</em> variants</h3>
<p id="Par11">We performed the MANO-B method using the 107 variants with various concentrations of four drugs. The difference in drug sensitivity among the variants was clearly demonstrated at high drug concentrations (Fig. <a href="#Fig2" class="usa-link">2</a>), and the optimal concentrations were thus determined to be 2.0, 0.5, 2.0, and 2.0 μM for olaparib, niraparib, rucaparib, and CBDCA, respectively.</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2. Comparative results of the MANO-B method with the IARC, ClinVar, and Align-GVGD classifications for 107 variants.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7244490_41467_2020_16141_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfb/7244490/afa09260f2f9/41467_2020_16141_Fig2_HTML.jpg" loading="lazy" id="d30e661" height="998" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>DLD1 <em>BRCA2</em> (−/−) cells transfected separately with the 107 <em>BRCA2</em> variants or the empty vector were treated with PARP inhibitors (olaparib, niraparib, and rucaparib), CBDCA, or DMSO at the indicated concentrations. The relative viability of the cells treated with each drug was calculated based on the viability of vehicle-treated cells, then normalized to that of cells expressing wild-type <em>BRCA2</em>. All variants were ordered by relative viability at the optimal concentration. The classification of the MANO-B method was based on the relative viability at the optimal concentration of each drug and defined as normal (relative viability of 1–82), intermediate (83–87), and abnormal (88–108). The IARC, ClinVar, and Align-GVGD classifications are color-coded in each column. The ClinVar classifications of five variants (V159E, M1168I, K1530N, G1696V, and A2911E) without assertion criteria were considered as VUSs.</p></figcaption></figure><p id="Par12">The relative viability of the cells treated with each drug was first calculated by comparing the viability with that of vehicle-treated cells, then normalized to that of cells expressing wild-type <em>BRCA2</em>. All variants were sorted by relative viability at the optimal concentrations. A scatter plot of the relative viability of olaparib and the other three drugs revealed an intermediate group including the P2329L, P2639L, D2913H, and S3291C mutants between the benign and pathogenic groups (Supplementary Fig. <a href="#MOESM1" class="usa-link">3</a>). With this intermediate group as a boundary, all known pathogenic variants showed lower relative viability, whereas all but two known benign variants—R2842H and V2908G—showed higher relative viability. The two variants were indeed shown to be hypomorphic by HDR assay in a previous study<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. In addition, we found that one likely pathogenic variant (N3187K) defined by ClinVar exhibited normal function as evaluated by the MANO-B method. This discordance between the functional classification and the clinical classification suggests potential errors in the clinical annotations for rare variants.</p>
<p id="Par13">We believe that the discrepancy in the classification of IARC Class 1/2 variants (R2842H and V2908G) that were evaluated as hypomorphic using the MANO-B method was because of the unreliable evidence which the IARC criteria was based on. The IARC classification is based on epidemiological evidence such as cosegregation data and other family-based genetic analyses<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. According to the Genome Aggregation Database, both R2842H and V2908G (minor allele frequency = 6.34 × 10<sup>−5</sup> and 1.69 × 10<sup>−5</sup>) were rare variants. Therefore, it might be difficult to obtain solid evidence for these variants.</p>
<p id="Par14">ClinVar, a clinical database curated by experts, also classified R2842H and V2908G as benign/likely benign, mainly based on co-occurrence analysis and functional data. R2842H was reported to co-occur with Q3066X, a truncating variant in BRCA2. According to the ACMG standards and guidelines, evidence that a variant is observed in trans with a pathogenic variant for a fully penetrant dominant gene/disorder is a supporting evidence indicating that the variant is benign<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. However, because a pathogenic BRCA2 variant is not fully penetrant, we believe that co-occurrence with a pathogenic variant cannot exclude the possibility that the variant is hypomorphic. For example, another hypomorphic variant R2784Q was reported to co-occur with pathogenic variants in BRCA1 and BRCA2<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>.</p>
<p id="Par15">Multiple and diverse functional assays for V2908G were reported by Wu et al. in 2005 and Farrugia et al. in 2008, who both belonged to the same research group<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>,<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>. However, ClinVar does not include two important studies reported by the same group in 2013 and 2018<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. The HDR activity of V2908G in their recent papers was decreased, indicating hypomorph of the variant. No other laboratories have replicated their experiments performed in 2005 and 2008. Thus, we considered V2908G a hypomorphic variant based on their latest reports and our result.</p>
<p id="Par16">To assess the pathogenicity of such variants accurately, the classification method must be based on a wide variety of evidence. Therefore, we reinterpreted all the 59 Class 1/2/4/5 variants (37 benign and 22 pathogenic) used in the MANO-B method according to the ACMG 2015 guidelines as previously described<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>,<a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup>. As a result, 18 variants (31%), including R2842H and V2908G, were classified into VUSs because of insufficient evidence (Supplementary Data <a href="#MOESM5" class="usa-link">2</a>). Furthermore, N3187K, defined as a likely pathogenic variant by ClinVar, is also defined as VUS according to both IARC and ACMG criteria. The criteria of the ACMG guidelines are more conservative and stringent than those of other classification methods because ACMG uses multiple criteria from different points of view and perspectives<sup><a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. This discrepancy among clinical databases implies potential errors in the interpretation of clinical variants. Moreover, the IARC and ACMG classification methods were designed for detecting high-risk pathogenic variants, and therefore, hypomorphic function variants or moderate cancer risk variants could be classified inappropriately<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>. Hence, we regard the discrepancy between functional and epidemiological evidence as reasonable.</p>
<p id="Par17">To evaluate the evenness of the pooled variant ratio, we collected cell pellets at day 0 (the day the drug treatment was started) to count the barcode reads by MiSeq. Regarding the raw data obtained from batch #1, the minimum, maximum, and median read counts were 778, 13,294, and 5763 for N55S, R3385H, and Y3098H, respectively. The distribution of each variant ratio is shown as a histogram (Supplementary Fig. <a href="#MOESM1" class="usa-link">4a</a>). A total of 97 variants (90%) were within the range of 0.5–2-fold average. We also calculated the fold change from day 0 to day 12 with dimethyl sulfoxide (DMSO) treatment (Supplementary Fig. <a href="#MOESM1" class="usa-link">4b</a>). The majority of cells expressing these variants generally exhibited a uniform growth, and the functions of the induced <em>BRCA2</em> variants did not have much impact on cell growth. The unevenness of the variant ratio probably has a small effect on the result of the MANO-B method because this method is based on fold-change calculation and the abundance bias is corrected through analysis.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Evaluation of 244 <em>BRCA2</em> variants by Bayesian inference</h3>
<p id="Par18">We expanded the experiment to encompass 244 variants, including 186 VUSs, at the optimal concentration of each drug, and obtained an assay dataset comprising 7344 individual viability values (Supplementary Data <a href="#MOESM6" class="usa-link">3</a> and <a href="#MOESM7" class="usa-link">4</a>). Using the optimal threshold for receiver operating characteristic (ROC) analysis, the estimated sensitivity and specificity of the MANO-B method for variant pathogenicity compared with those of the IARC classification system were 100% and 95% (95% confidence intervals: 85–100% and 82–99%), respectively (Supplementary Fig. <a href="#MOESM1" class="usa-link">5</a>).</p>
<p id="Par19">Given that the existence of hypomorphic variants was suggested, a nondichotomous mathematical approach was explored to precisely determine the pathogenicity of each variant. Relative viability data were log normalized and compensated using the values of the wild-type and the D2723H variant as standard values for benign and pathogenic variants, respectively. The resulting viability data followed a two-component Gaussian mixture model by the expectation–maximization algorithm (Supplementary Fig. <a href="#MOESM1" class="usa-link">6</a>).</p>
<p id="Par20">In the following analysis, we adopted the Bayes factor (BF) as the strength of evidence in favor of pathogenicity. To calculate the BF, we utilized a Bayesian hierarchical two-component Gaussian mixture model based on the VarCall model<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup> with a noninformative prior probability. In this setting, the BFs were calculated as the probability ratio of a variant being functionally abnormal to it being normal. A five-tiered functional classification based on the BF was assigned to each variant according to established criteria consistent with the ACMG variant evaluation guidelines as follows<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>: fClass 1 (normal; BF ≤ 0.003), fClass 2 (likely normal; 0.003 &lt; BF ≤ 0.053), fClass 3 (intermediate; 0.053 &lt; BF &lt; 18.7), fClass 4 (likely abnormal; 18.7 ≤ BF &lt; 350), or fClass 5 (abnormal; 350 ≤ BF).</p>
<p id="Par21">The function of a variant, <em>v</em>, was estimated by a variant-specific effect, <em>η</em><sub><em>v</em></sub>. Using 22 known pathogenic and 37 known benign variants as the training set, the <em>η</em><sub><em>v</em></sub> values of benign and pathogenic variants were gradually distributed (Supplementary Fig. <a href="#MOESM1" class="usa-link">7</a>). The sensitivity and specificity of the Bayesian inference for detecting IARC class 4/5 variants were 95% and 95% (95% confidence intervals: 77–100% and 82–99%), respectively. When a variant is classified as fClass 4/5, the odds ratio of pathogenicity come out a 17.7:1 in favor of pathogenicity. We also analyzed the concordance between the ACMG classification and the MANO-B classification. All the 41 benign/pathogenic variants (22 benign and 19 pathogenic) used in the MANO-B method were clearly divided into two groups, and the odds ratio of pathogenicity is infinity (Supplementary Fig. <a href="#MOESM1" class="usa-link">8</a>). Thus, the BF-based functional classification by the MANO-B method provides strong evidence of pathogenicity in the framework of the ACMG guidelines<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>.</p>
<p id="Par22">To validate the BF-based classification from the functional perspective, we set two functional classification thresholds determined by the ACMG benign/pathogenic variants to classify the following three components according to a previous report: functionally normal, intermediate, and abnormal<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. The higher threshold between normal and intermediate components is defined as the minimal effect of benign variants according to the ACMG criteria (R18H, <em>η</em><sub><em>v</em></sub> = −1.38), whereas the lower threshold between intermediate and abnormal components is defined as the maximal effect of pathogenic variants (C2535X truncate variant, <em>η</em><sub><em>v</em></sub> = −2.17). As a result, all the functional effects of fClass 1/2 variants were above the higher threshold, whereas all those of fClass 4/5 variants were below the lower threshold. Now, fClass 4/5 variants can be regarded as pathogenic because their probability is in the abnormal component and their functional levels are equivalent to those of the known pathogenic variants.</p>
<p id="Par23">Notably, the fClass values of the individual variants for the four drugs were concordant (Fig. <a href="#Fig3" class="usa-link">3a–c</a>). The data for 0.5 μM niraparib exhibited the highest resolution in the evaluation of the variants of intermediate function. We assume that the difference in functional estimation among drugs in the MANO-B method was primarily because the drug concentrations of olaparib and rucaparib were not as optimal as that of niraparib. The concentration of 2.0 μM of olaparib, rucaparib, and CBDCA was probably too high for DLD1 cells expressing hypomorphic variants to survive, considering that the cell viability assay with 1 µM of olaparib, rucaparib, and carboplatin (Supplementary Fig. <a href="#MOESM1" class="usa-link">2b</a>) demonstrated broader transitional zones between benign and pathogenic variants. Among the 186 VUSs analyzed in the full dataset with niraparib, 98, 28, 23, 6, and 31 variants were classified as fClass 1–5, respectively (Fig. <a href="#Fig3" class="usa-link">3d</a>, Supplementary Data <a href="#MOESM8" class="usa-link">5</a>). All variants outside functional domains belonged to fClass 1/2. Most abnormal variants were located in the DNA-binding domain (DBD). Other intermediate or abnormal variants were W31C/G/L in the transactivation domain (TAD)<sup><a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>, P2329L in the MEILB2-binding domain (MBD)<sup><a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>, and S3291C in the C-terminal domain (CTD), which is a key phosphorylation site for BRCA2–RAD51 interaction<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3. Evaluation of 244 <em>BRCA2</em> variants by applying Bayesian inference to the MANO-B method.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7244490_41467_2020_16141_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfb/7244490/6d7e9d286c14/41467_2020_16141_Fig3_HTML.jpg" loading="lazy" id="d30e913" height="861" width="780" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p><strong>a</strong>–<strong>c</strong> Functional classification by the MANO-B method with four drugs. A total of 244 <em>BRCA2</em> variants were classified by Bayesian inference. The number of variants classified for each drug as fClass 1/2 (<strong>a</strong>), fClass 3 (<strong>b</strong>), and fClass 4/5 (<strong>c</strong>) is shown. No variant was classified as fClass 1/2 with one drug and fClass 4/5 with another drug. <strong>d</strong> Bar plots of functional variant effects and functional diagnosis of 244 <em>BRCA2</em> variants mapped against the <em>BRCA2</em> full-length sequence and domains. The key domains of <em>BRCA2</em> consist of a PALB2 interaction domain encompassing amino acids (a.a.) 10–40, a transactivation domain (TAD) encompassing a.a. 18–105, a RAD51-binding domain including eight BRC repeats encompassing a.a. 1008–2082, an MEILB2-binding domain (MBD) encompassing a.a. 2117–2339, a DNA-binding domain encompassing a.a. 2402–3186 and containing a helical domain (HD) encompassing a.a. 2402–2669, oligonucleotide/oligosaccharide-binding domains (OBs) (OB) encompassing a.a. 2670–2803, 2809–3048, and 3056–3102, and a C-terminal RAD51-binding domain (CTD) encompassing a.a. 3270–3305. The function of each variant was estimated as a variant-specific effect value, <em>η</em><sub><em>v</em></sub>, based on a two-component model. Data of niraparib are shown as a representative case. The upper and lower components correspond to normal function and loss-of-function, respectively. The dotted lines indicate the median value of each component. The classification of each variant based on the Bayes factor (BF) is indicated by the color and shape of the lines and plots, as shown in the legend. Variant functions were classified into five classes by the MANO-B method: fClass 1 (normal) (BF ≤ 0.003), fClass 2 (likely normal) (0.003 &lt; BF ≤ 0.053), fClass 3 (intermediate) (0.053 &lt; BF &lt; 18.7), fClass 4 (likely abnormal) (18.7 ≤ BF &lt; 350), and fClass 5 (abnormal) (350 ≤ BF). <em>N</em> = 3 cells were examined over 2 or 3 independent experimental batches. Plots indicate mean values. Open error bars, 95% CIs. WT, wild-type; NS, nonsense variants.</p></figcaption></figure><p id="Par24">This Bayesian model allowed a combinational classification based on log-normalized relative viability data with prior probability, such as the Align-GVGD classification based on the evolutionary conservation and biophysical properties of amino acids<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup> (Supplementary Fig. <a href="#MOESM1" class="usa-link">9</a>). However, this combinational classification for variants outside the DBD should be interpreted with caution because no reliable prior probability data have been established for this region.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Model validation</h3>
<p id="Par25">The internal validation of our model was confirmed by posterior predictive checks. The posterior predictive distribution of the log-normalized relative viability matched the observed data (Supplementary Fig. <a href="#MOESM1" class="usa-link">10a</a>). Quantile–Quantile (Q–Q) plots showed that the posterior expected standardized residuals of relative viability exhibited a normal distribution (Supplementary Fig. <a href="#MOESM1" class="usa-link">10b</a>). Furthermore, a strong correlation between the MANO-B method and the HDR assay for 24 selected variants was confirmed (Supplementary Fig. <a href="#MOESM1" class="usa-link">11</a>). The results of the two assays revealed a small discordance in some variants. The S3291C variant exhibited a relatively high value in the HDR assay compared to that in the MANO-B method, probably because S3291 is the phosphorylation site for CDK1/2 and the HDR assay cannot evaluate its function exactly<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>.</p></section><section id="Sec8"><h3 class="pmc_sec_title">Accurate BRCA Companion Diagnostic (ABCD) test</h3>
<p id="Par26">To rapidly evaluate the pathogenicity of <em>BRCA2</em> VUSs in the clinic, the Accurate BRCA Companion Diagnostic (ABCD) test was developed as a potential companion diagnostic for PARP inhibitor treatment. Newly detected <em>BRCA2</em> cDNAs, along with four control variants for benign (wild-type and T2515I) and pathogenic (Y2660D and D2723H) variants, were generated for assessment by a small-scale MANO-B method. The resulting data correlate with the data from previous MANO-B experiments, enabling batch effect adjustment for pathogenicity determination. When a <em>BRCA2</em> VUS is believed to be related to splicing aberration, its mRNA should be evaluated by RNA sequencing of patient samples<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a></sup>. Any aberrant <em>BRCA2</em> transcripts detected should also be subjected to the ABCD test (Fig. <a href="#Fig4" class="usa-link">4</a>).</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4. The Accurate BRCA Companion Diagnostic (ABCD) test for the clinical functional annotation of novel <em>BRCA2</em> VUSs.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=7244490_41467_2020_16141_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4cfb/7244490/d1bb659a54d0/41467_2020_16141_Fig4_HTML.jpg" loading="lazy" id="d30e985" height="389" width="675" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Schematic representation of the ABCD test. <em>BRCA2</em> variants were investigated by genomic DNA sequencing. The effect of variants on mRNA splicing was evaluated by RNA sequencing to detect the aberrant <em>BRCA2</em> transcripts. All detected cDNAs, including four control variants for functionally normal (wild-type and T2515I) and abnormal (Y2660D and D2723H) variants and four variants of interest, were generated for assessment by the small-scale MANO-B method in a 12-well plate. Technical and biological triplicate experiments using niraparib at 0.5 μM are recommended. Data analysis was performed with data from previous experiments, enabling batch effect adjustment. The experimental steps and required times are indicated.</p></figcaption></figure><p id="Par27">An experiment was designed to confirm the accuracy of the ABCD test, in which I1929V, D3095E, Y3035S, and S3291C were assessed as if they were novel variants. The classification of normal and abnormal variants was almost reproducible and consistent with that observed for previous large-scale batches; however, the classification of the D3095E pathogenic variant in batch #1 was underdiagnosed (from fClass 5 to fClass 4, Table <a href="#Tab1" class="usa-link">1</a>). One misclassification is crucial in case we judge the clinical application based on the result of a single batch. Because transfection efficiency might cause inconsistent results in the ABCD test, we recognized the importance of multiple independent transfections using different batches of mutants to ensure the accuracy of the assay. Therefore, we combined the results from three batches with different transfections and performed a statistical analysis to annotate the pathogenicity. This approach improved the consistency (4/4, 100%) between the ABCD test and the large-scale MANO-B method, although the validation study remains to be performed in a larger scale.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Results of an experimental ABCD test.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th colspan="1" rowspan="1">Variant</th>
<th colspan="1" rowspan="1">IARC classification</th>
<th colspan="1" rowspan="1">ABCD test</th>
<th colspan="1" rowspan="1">
<em>η</em><sub><em>v</em></sub>
</th>
<th colspan="1" rowspan="1">Bayes factor</th>
<th colspan="1" rowspan="1">fClass</th>
</tr></thead>
<tbody>
<tr>
<td colspan="1" rowspan="1">I1929V</td>
<td colspan="1" rowspan="1">Class 1</td>
<td colspan="1" rowspan="1">Previous batches</td>
<td colspan="1" rowspan="1">0.37 (−0.02 to 0.79)</td>
<td colspan="1" rowspan="1">1.05 × 10<sup>−5</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-1</td>
<td colspan="1" rowspan="1">0.19 (−0.33 to 0.73)</td>
<td colspan="1" rowspan="1">1.02 × 10<sup>−5</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-2</td>
<td colspan="1" rowspan="1">−0.23 (−0.73 to 0.28)</td>
<td colspan="1" rowspan="1">1.63 × 10<sup>−4</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-3</td>
<td colspan="1" rowspan="1">0.08 (−0.43 to 0.6)</td>
<td colspan="1" rowspan="1">3.71 × 10<sup>−5</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Three batches combined</td>
<td colspan="1" rowspan="1">0.11 (−0.23 to 0.44)</td>
<td colspan="1" rowspan="1">1.40 × 10<sup>−5</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Y3035S</td>
<td colspan="1" rowspan="1">Class 2</td>
<td colspan="1" rowspan="1">Previous batches</td>
<td colspan="1" rowspan="1">−0.63 (−1.01 to −0.25)</td>
<td colspan="1" rowspan="1">1.11 × 10<sup>−3</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-1</td>
<td colspan="1" rowspan="1">−0.55 (−1.05 to −0.04)</td>
<td colspan="1" rowspan="1">1.12 × 10<sup>−3</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-2</td>
<td colspan="1" rowspan="1">−0.53 (−1.04 to −0.02)</td>
<td colspan="1" rowspan="1">9.57 × 10<sup>−4</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-3</td>
<td colspan="1" rowspan="1">−0.36 (−0.87 to 0.16)</td>
<td colspan="1" rowspan="1">3.01 × 10<sup>−4</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Three batches combined</td>
<td colspan="1" rowspan="1">−0.47 (−0.79 to −0.15)</td>
<td colspan="1" rowspan="1">2.79 × 10<sup>−4</sup>
</td>
<td colspan="1" rowspan="1">fClass 1</td>
</tr>
<tr>
<td colspan="1" rowspan="1">D3095E</td>
<td colspan="1" rowspan="1">Class 5</td>
<td colspan="1" rowspan="1">Previous batches</td>
<td colspan="1" rowspan="1">−3 (−3.41 to −2.62)</td>
<td colspan="1" rowspan="1">1.33 × 10<sup>4</sup>
</td>
<td colspan="1" rowspan="1">fClass 5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-1</td>
<td colspan="1" rowspan="1">−2.31 (−2.8 to −1.78)</td>
<td colspan="1" rowspan="1">4.45 × 10<sup>1</sup>
</td>
<td colspan="1" rowspan="1">fClass 4</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-2</td>
<td colspan="1" rowspan="1">−2.63 (−3.12 to −2.15)</td>
<td colspan="1" rowspan="1">5.75 × 10<sup>2</sup>
</td>
<td colspan="1" rowspan="1">fClass 5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-3</td>
<td colspan="1" rowspan="1">−2.69 (−3.2 to −2.19)</td>
<td colspan="1" rowspan="1">9.28 × 10<sup>2</sup>
</td>
<td colspan="1" rowspan="1">fClass 5</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Three batches combined</td>
<td colspan="1" rowspan="1">−2.52 (−2.85 to −2.19)</td>
<td colspan="1" rowspan="1">7.85 × 10<sup>2</sup>
</td>
<td colspan="1" rowspan="1">fClass 5</td>
</tr>
<tr>
<td colspan="1" rowspan="1">S3291C</td>
<td colspan="1" rowspan="1">Unclassified</td>
<td colspan="1" rowspan="1">Previous batches</td>
<td colspan="1" rowspan="1">−2.07 (−2.43 to −1.69)</td>
<td colspan="1" rowspan="1">1.15 × 10<sup>1</sup>
</td>
<td colspan="1" rowspan="1">fClass 3</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-1</td>
<td colspan="1" rowspan="1">−1.06 (−1.7 to −0.53)</td>
<td colspan="1" rowspan="1">6.15 × 10<sup>−2</sup>
</td>
<td colspan="1" rowspan="1">fClass 3</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-2</td>
<td colspan="1" rowspan="1">−2.06 (−2.6 to −1.34)</td>
<td colspan="1" rowspan="1">7.05 × 10<sup>0</sup>
</td>
<td colspan="1" rowspan="1">fClass 3</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">New batch-3</td>
<td colspan="1" rowspan="1">−1.35 (−2.12 to −0.74)</td>
<td colspan="1" rowspan="1">3.17 × 10<sup>−1</sup>
</td>
<td colspan="1" rowspan="1">fClass 3</td>
</tr>
<tr>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1"></td>
<td colspan="1" rowspan="1">Three batches combined</td>
<td colspan="1" rowspan="1">−1.46 (−1.86 to −1.11)</td>
<td colspan="1" rowspan="1">3.39 × 10<sup>−1</sup>
</td>
<td colspan="1" rowspan="1">fClass 3</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p33"><p>Data are presented as means (95% credible interval).</p></div></div></section></section></section><section id="Sec9"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par28">Several functional assays for <em>BRCA2</em> variants have been developed to date based on the various functions of BRCA2 protein. However, it should be noted that loss of a certain function does not directly lead to cancer predisposition. For example, an established R3052W pathogenic variant did not show pathogenicity in the centrosome amplification assay<sup><a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup>, whereas G2353R, once annotated as a benign variant, showed a pathogenic response in the spontaneous homologous recombination assay<sup><a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>. The results of each functional assay should be carefully interpreted together with clinical genetic data.</p>
<p id="Par29">It is remarkable that the distribution of the functional parameter <em>η</em><sub><em>v</em></sub> for the MANO-B method was continuous from the normal to the abnormal component and not clearly segregated into two components, in accordance with the HDR assay<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>, suggesting the existence of variants of intermediate function<sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>.</p>
<p id="Par30">For the nondichotomous classification, a high-resolution quantitative assay together with an appropriate inference method are necessary. In the MANO-B method, all cell clones with individual variants are evenly mixed and cultured in one dish. Since each clone grows competitively under the same culture conditions, including pH, temperature, and drug concentration, we can minimize the technical error and bias and evaluate even small differences in BRCA function among the variants. This is an advantage over other methods such as the cell viability assay and the HDR assay, which test variants individually.</p>
<p id="Par31">Recently, Findlay et al. reported a robust saturation genome editing method by the use of a haploid cell line, HAP1, that depends on the HDR pathway for growth<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a></sup>. In contrast to the MANO-B method, their technology may accurately evaluate the function of variants at the splicing sites or the promoters of <em>BRCA</em> genes. On the other hand, our method uses a diploid cell line and, therefore, may better reflect HDR function in physiological conditions. The MANO-B method is, further, able to directly interrogate the sensitivity of each VUS to different PARP inhibitors. The MANO-B method and the saturation genome editing method may thus be complementary to each other.</p>
<p id="Par32">While clinical gene testing has identified plenty of <em>BRCA2</em> variants, most VUSs are rare and thus there is a lack of substantial familial data. Recently, the uncommon (but not rare) variants G2508S (IARC Class 4) and Y3035S (IARC Class 2) were reported in a large case–control study showing indecisive cancer predisposition<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>. These two variants demonstrate the clinical utility of the MANO-B method for clinical annotation of VUSs well. G2508S (<em>η</em><sub><em>v</em></sub> = −2.42, fClass 4) showed hypomorphism, while Y3035S (<em>η</em><sub><em>v</em></sub> = −0.63, fClass 1) showed normal function, although the possibility of splicing aberration by the c.9104A&gt;C single nucleotide variation was not excluded. We consider that G2508S is a hypomorphic variant because the familial data is consistent with the functional result, whereas the pathogenicity of Y3035S is indeterminate because of the conflict among the data. The clinical annotation of such uncommon variants could be assessed by a combinational approach, although additional clinical data are needed to identify the optimal thresholds for the MANO-B method. It is not yet known how to deal with patients harboring <em>BRCA2</em> hypomorphic variants. However, we believe these patients may be eligible for PARP inhibitor treatment. Assessing the <em>BRCA</em> status may be a good option to predict the effectiveness of PARP inhibitors.</p>
<p id="Par33">Overall, the MANO-B method is a robust and scalable analysis approach for evaluating the function of <em>BRCA2</em> variants. As we developed a dataset of 244 <em>BRCA2</em> variants, including controls, additional independent analysis can be merged for precise evaluation using batch effect compensation. Importantly, this technique is applicable to the high-throughput functional assessment of other tumor suppressor genes, augmenting the functional data for rare variants and identifying the association of these variants with cancer susceptibility.</p>
<p id="Par34">Furthermore, the ABCD test may be useful as a companion diagnostic for PARP inhibitor treatment in patients newly identified as <em>BRCA2</em> VUS carriers. There are two scenarios in which the result of the MANO-B method could be applied to patients in the framework of the ACMG guidelines; one is for predicting the effectiveness of PARP inhibitors for patients with cancer harboring <em>BRCA2</em> VUSs, and the other is for cancer risk stratification for considering prophylactic surgery to prevent cancer in patients who at the time are healthy. In the former scenario, clinicians could decide on the use of PARP inhibitors for patients with cancer harboring <em>BRCA2</em> VUSs to prevent tumor progression. Therefore, an evaluation of <em>BRCA</em> function using the ABCD test could be a companion diagnostic method for PARP inhibitor treatment, although the clear threshold of fClass as a marker to predict which variant is actually beneficial for PARP inhibitor treatment in the clinical setting should be determined by clinical trials. In the latter scenario, healthy patients with hereditary <em>BRCA2</em> VUSs can wait and observe for several years for the tumor to emerge. After receiving positive genetic test results, approximately half of the women wait more than 12 months before undergoing prophylactic salpingo-oophorectomy<sup><a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>. For patients with fClass 5 variant evaluated by MANO-B method, the application of prophylactic surgery could be considered carefully along with genetic counseling because the possibility of these patients to develop cancer may be high. The penetration rate of cancer likely depends on the extent of <em>BRCA</em> function deficiency; healthy patients with a <em>BRCA</em> variant of fClass 3 or 4 might be referred to careful check-up rather than prophylactic surgery.</p>
<p id="Par35">Tumor response to PARP inhibitor therapy has several biomarkers other than <em>BRCA</em>1/2 inactivation, such as <em>EMSY</em> amplification, Fanconi anemia pathway inactivation, and other HR gene defects<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. Therefore, it is a good method to evaluate <em>BRCA</em> status by whole-genome sequencing of tumors based on mutation and rearrangement signatures without the knowledge of the precise causative mutations<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a>,<a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. Nones et al. demonstrated that 21 breast cancers from 22 <em>BRCA2</em> pathogenic variant carriers (95%) in their study exhibited reduced <em>BRCA</em> function, whereas only one was <em>BRCA</em>-proficient<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. In contrast to the test of BRCA function, the ABCD test is a simple functional method for evaluating <em>BRCA2</em> variant pathogenicity. Although the ABCD test cannot explain the <em>BRCA</em> status of non-<em>BRCA1/2</em> tumors, it is a rapid and precise method that directly evaluates the PARP inhibitor sensitivity of cancers harboring <em>BRCA2</em> VUSs. In addition, an advantage of the ABCD test over <em>BRCA</em> functional analysis is that the ABCD test can evaluate whether germline <em>BRCA</em> variants found in people without cancer are pathogenic variants predisposing to cancer. Therefore, both the ABCD test and the whole-genome sequencing of tumors could be used in parallel for the assessment of <em>BRCA</em> status. As the ABCD test reported in this study was limited to <em>BRCA</em> functional analysis, we sought to apply this test to other HR genes in the future.</p>
<p id="Par36">There are several limitations regarding the use of the MANO-B method for clinical annotation. The MANO-B method evaluates HDR function of <em>BRCA2</em> variants via PARP inhibitor sensitivity and estimates their pathogenicity indirectly. This method does not directly consider other <em>BRCA2</em> functions, such as the regulation of the G2–M transition or transcriptional elongation<sup><a href="#CR49" class="usa-link" aria-describedby="CR49">49</a>,<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>. Although the high concordance of the MANO-B method with the IARC and ACMG classifications suggest that <em>BRCA2</em> pathogenicity can be evaluated primarily by investigating HDR activity, we would like to note that BFs for abnormal do not have a direct correlation with the likelihood ratios for pathogenicity, as the normal or abnormal variants defined by this functional assay are not necessarily benign or pathogenic variants in the clinical setting. In fact, there are discrepancies between the functional interpretation by drug sensitivity and clinical annotation of ClinVar in some variants, such as R2842H and V2908G. Those variants were mostly hypomorphic variants or very rare variants that have not been reviewed by expert panels in ClinVar. Therefore, the accurate cancer risks of these variants need to be evaluated carefully. For these reasons, we expect that the functional classification should be used as evidence of pathogenicity and combined with other evidence in a comprehensive framework of ACMG guidelines. We believe that our functional evaluation by drug sensitivity might adjust the interpretation of cancer risks, especially of those variants, although further validation studies are needed.</p>
<p id="Par37">There are also several limitations of our cDNA-based assay. This approach cannot rule out potential effects on splicing. Importantly, although there are some computational predictors for possible splicing aberrations, either algorithms could not demonstrate adequate reliability for clinical usage, especially for variants outside of the consensus splice sites<sup><a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>. Comprehensive splicing functional assays such as hybrid minigene assay and saturation genome editing technique would reinforce the evidence<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR52" class="usa-link" aria-describedby="CR52">52</a>,<a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>. It is also recommended to perform RNA-seq of patient blood and tumor to detect aberrantly spliced mRNA. In addition, the MANO-B method was performed in this study using only one colorectal cancer cell line. There is no evidence of the increased risk of colorectal cancer in <em>BRCA2</em> pathogenic mutation carriers<sup><a href="#CR54" class="usa-link" aria-describedby="CR54">54</a></sup>, and it is unclear whether the result of the MANO-B method is reproducible in other cell lines. To evaluate the variant functions precisely and robustly, replication studies with multiple cell lines with various homologous recombination statuses are desired. Although it is noteworthy that the high copy number of integrated BRCA2 constructs was necessary to obtain induced mRNA expression at levels similar to endogenous expression, the regulation of CMV promoter-driven exogenous expression of BRCA2 would not be physiologically relevant.</p>
<p id="Par38">It is possible that the MANO-B method may lead to a better understanding of cancer biology and provide a concept of clinical functional annotation to improve cancer diagnosis and treatment.</p></section><section id="Sec10"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec11"><h3 class="pmc_sec_title">Cell lines and culture conditions</h3>
<p id="Par39">Human colorectal adenocarcinoma cell line DLD1 parental cells and homozygous <em>BRCA2</em> (−/−) variant cells were purchased from Horizon Discovery, Inc. Cells were cultured in RPMI 1640 medium containing 10% fetal bovine serum and 2 mM <span class="font-variant-small-caps">l</span>-glutamine at 37 °C in 5% CO<sub>2</sub> and passaged at 70–90% confluency with TrypLE Express (all from Thermo Fisher Scientific).</p></section><section id="Sec12"><h3 class="pmc_sec_title">Choice of variants</h3>
<p id="Par40">A total of 239 <em>BRCA2</em> missense variants identified in the BRCA Exchange database were selected. Sequence nomenclature was based on Human Genome Variant Society (HGVS) and National Center for Biotechnology Information (NCBI) reference <a href="https://www.ncbi.nlm.nih.gov/protein/NP_000050.2" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_000050.2</a>: p.V2466A. We randomly selected 155 variants from functional domains and an additional 89 variants outside functional domains from throughout the coding sequence. Variants in functional domains were selected considering Align-GVGD in silico prediction. Between 14 and 19 VUSs were randomly selected from each of the five Align-GVGD C15–C55 categories, and 62 variants were randomly selected from the C65 category. The proportion of each category was defined as previously reported<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. An additional five nonsense variants thought to be definitely pathogenic were selected as controls (Supplementary Data <a href="#MOESM6" class="usa-link">3</a>). Eight VUSs located in the last 3 exonic bases of the splice donor site and five VUSs located in the first 2 exonic bases of the splice acceptor site were possible candidates for disrupting splice consensus sequences. These VUSs were analyzed using Splicing Prediction in Consensus Element (SPiCE) v2.1.3<sup><a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>, the most accurate in silico splice site prediction algorithm for <em>BRCA1/2</em>. Only six variants—V159M (c.475G&gt;A), D23Y (c.67G&gt;T), V211I (c.631G&gt;A), R2336P (c.7007G&gt;C), and R2602T (c.7805G&gt;C)—were predicted to alter canonical splicing, and we assessed the effect of these variants on protein function by the MANO-B method (Supplementary Data <a href="#MOESM6" class="usa-link">3</a>).</p></section><section id="Sec13"><h3 class="pmc_sec_title">Plasmid construction</h3>
<p id="Par41">The piggyBac transposon vector was constructed by inserting a random 10-bp DNA barcode sequence between the CMV promoter and the multiple cloning site of the piggyBac dual promoter vector (PB513B-1; System Biosciences). The <em>GFP</em> sequence in the piggyBac vector was deleted by a site-directed mutagenesis technique for the direct repeat-green fluorescent protein (DR-GFP) assay. The full-length wild-type cDNA of human <em>BRCA2</em> was subcloned from pcDNA3 236HSC WT (Addgene plasmid # 16246) into the piggyBac vector. Plasmids encoding <em>BRCA2</em> variants were developed by a site-directed mutagenesis technique with variant-specific primers designed using an online tool (QuikChange Primer Design; <a href="https://www.agilent.com/store/primerDesignProgram.jsp" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.agilent.com/store/primerDesignProgram.jsp</a>). The primers used for mutagenesis are listed in Supplementary Data <a href="#MOESM6" class="usa-link">3</a>. For western blot analysis, the N-terminal FLAG-tag (DYKDDDDK) was inserted in the piggyBac-<em>BRCA2</em> wild-type by site-directed mutagenesis, and then the 19 <em>BRCA2</em> variants were also subcloned into the FLAG-<em>BRCA2</em>-piggyBac vector. Plasmids were fragmented by an E220 Focused-ultrasonicator (Covaris, Inc.) to an average size of 300 bp, ligated with adaptors, and sequenced using MiSeq (Illumina). All the entire <em>BRCA2</em> cDNA sequences, including the ones with point mutations generated by site-directed mutagenesis, the unique barcode sequences, and the piggyBac vector backbone sequences of every plasmid were confirmed by our original pipeline. Next-generation sequencing (NGS) data were aligned by Bowtie2 v2.3.4.2 against the reference sequence composed of wild-type <em>BRCA2</em> cDNA and the piggyBac vector and analyzed with samtools v1.9, bcftools v1.9, and IGV v2.4.10 software (Broad Institute). Plasmids harboring undesirable mutations were discarded. Therefore, all plasmids in this study had only target variants and unique barcode sequences without additional mutations. The hyperactive piggyBac transposase expression vector (pCMV-hyPBase) was provided by Trust Sanger Institute. pCBASceI and pHPRT-DRGFP were a gift from Maria Jasin (Addgene plasmid # 26477 and # 26476, respectively). The puromycin antibiotic selection marker for pHPRT-DRGFP was replaced with the Sh_ble zeocin resistance gene. To construct the piggyBac-DRGFP vector, the ends of the XhoI-SacI-digested DRGFP reporter fragment and the SpeI-ApaI-digested piggyBac transposon vector were blunted and ligated to each other.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Stable transfection with the piggyBac transposon</h3>
<p id="Par42">The lipid-based method was used to transfect DLD1 cells with the plasmid constructs. Transfections were performed with exactly one unique plasmid per well. This is essential to guarantee that cells were transduced with only one variant. The same clone of each plasmid harboring a variant was used for all independent batches. Twenty-four hours before transfection, cells were seeded in 96-well plates at a density of 1 × 10<sup>4</sup> cells/well. Prior to transfection, the culture medium was replaced with 100 µl of fresh medium. The transfection mixture for individual wells comprised 100 ng of the piggyBac transposon vector, 50 ng of pCMV-hyPBase, 0.5 µl of Lipofectamine Stem Transfection Reagent (Thermo Fisher Scientific), and 50 µl of Opti-MEM I Reduced Serum Medium (Thermo Fisher Scientific). The transfection mixture was added to each well after 20 min of incubation at room temperature. Two days after transfection, cells were cultured with antibiotics (3 μg/ml puromycin for piggyBac-<em>BRCA2</em> and 100 μg/ml zeocin for piggyBac-DRGFP) for 7 days. Puromycin-resistant polyclonal cell populations harboring piggyBac-<em>BRCA2</em> were used directly for assays, while a genetically homogeneous cloned cell line harboring piggyBac-DRGFP was generated from a single cell.</p></section><section id="Sec15"><h3 class="pmc_sec_title">Digital droplet PCR</h3>
<p id="Par43">Digital droplet PCR was performed using a QX100 Droplet Digital PCR system (Bio-Rad Laboratories) with <em>BRCA2</em> cDNA primers and probe and <em>BRCA2</em> intron primers and probe, both at a final concentration of 900 nM primers and 250 nM probe. The sequences are shown in Supplementary Table <a href="#MOESM1" class="usa-link">1</a>. Aqueous droplets with a 20-µl volume containing final concentrations of 1× Droplet Digital PCR Supermix for probes (Bio-Rad Laboratories) and 100 ng of the genomic DNA template were generated. PCR amplification was conducted using a T100 Thermal Cycler under the manufacturer-recommended conditions. After amplification, the digital PCR data were collected and analyzed using a Bio-Rad QX100 droplet reader and QuantaSoft v1.6.6.0320 software. Crosshair gating was used to automatically split the data into four quadrants by the software’s normal setting. Approximately 15,000 droplets were analyzed per well. The induced <em>BRCA2</em> cDNA copy number was calculated based on the observation that DLD1 cells are a pseudodiploid human cell line and the copy number of the endogenous <em>BRCA2</em> gene is considered to be 2. The 95% confidence intervals were estimated by a Poisson distribution model.</p></section><section id="Sec16"><h3 class="pmc_sec_title">Real-time quantitative RT-PCR</h3>
<p id="Par44">Freshly recovered DLD1 <em>BRCA2</em> (−/−) cells with 20 variants of <em>BRCA2</em>, untransduced DLD1 <em>BRCA2</em> (−/−) cells, and DLD1 parental cells were pelleted. Total RNA was extracted from these pellets with RNA-Bee reagent following the manufacturer’s instructions. DNase I digestion was performed to minimize DNA contamination, and RNA-Bee purification was repeated to inactivate DNase I. The reverse transcription reaction used 1 µg of total RNA from each sample with SuperScript IV VILO reverse transcriptase. The resulting cDNAs were subsequently used for two-step quantitative RT-PCR with Power SYBR Green PCR Master Mix (Thermo Fisher Scientific) on a 7500HT Fast Real-Time PCR System (Thermo Fisher Scientific). The primers specific for <em>BRCA2</em> exon 11 and <em>ACTB</em> are shown in Supplementary Table <a href="#MOESM1" class="usa-link">1</a>. The amplified <em>BRCA2</em> sequence was present in parental cells but absent from <em>BRCA2</em> (−/−) cells; therefore, mRNA detected in the <em>BRCA2</em> (−/−) cells was derived from induced cDNA. The relative <em>BRCA2</em> expression levels were normalized to the expression levels of the housekeeping gene <em>ACTB</em>. Experiments were performed in technical triplicate, including DLD1 parental cells and DLD1 <em>BRCA2</em> (−/−) cells transfected with empty vector control. Then, the expression data were further normalized to the corresponding expression levels in DLD1 parental cells. The results are shown as the averages of biological triplicate experiments.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Western blotting</h3>
<p id="Par45">Whole-cell lysates from DLD1 <em>BRCA2</em> (−/−) cells harboring 20 variants of the N-terminal FLAG-tagged <em>BRCA2</em> cDNA and the empty piggyBac vector were prepared with sodium dodecyl sulfate (SDS) sample buffer containing 2-mercaptoethanol (Sigma). The cell lysates (70 µg/sample for FLAG-BRCA2 and 10 µg/sample for beta-Actin) were incubated with the sample buffer for 20 min at 50 °C or for 3 min at 95 °C, respectively, and subjected to SDS polyacrylamide gel electrophoresis on 6% (FLAG-BRCA2) or 10% (beta-Actin) polyacrylamide gels. Precision Plus Protein All Blue Standards (Bio-Rad Laboratories) were run as molecular weight markers along with samples. Electrophoresis was performed at 150 V, and the gels were transferred to an Immobilon-P transfer membrane (Millipore) for 3 h at 50 V. The membranes were blocked with 5% nonfat dry milk in 0.05% Tween 20 containing Tris-buffered saline (TBST) at room temperature for 1 h, and then incubated with a 500-fold diluted primary anti-FLAG antibody (F3165; Sigma) or a 2000-fold diluted primary anti-beta-Actin antibody (#4970; Cell Signaling Technology) in TBST at 4 °C for 16 h. Subsequently, the membranes were incubated with 10,000-fold diluted peroxidase-linked secondary antibody (NA931V for FLAG-BRCA2 and NA934V for beta-Actin; GE Healthcare) at room temperature for 4 h. The target proteins were visualized by an enhanced chemiluminescence reagent, SuperSignal West Femto (GE Healthcare).</p></section><section id="Sec18"><h3 class="pmc_sec_title">Cell viability assay</h3>
<p id="Par46">DLD1 <em>BRCA2</em> (−/−) cells harboring 20 variants of <em>BRCA2</em> cDNA and empty vector, untransduced DLD1 <em>BRCA2</em> (−/ −) cells, and DLD1 parental cells were seeded in 96-well plates at a density of 2.0 × 10<sup>3</sup> cells/well with 100 µl of medium/well, and each drug was added at various concentrations: olaparib (50 nM–5 µM, Selleckchem), niraparib (10 nM–1 µM, Selleckchem), rucaparib (50 nM–5 µM, LC Laboratories), and CBDCA (50 nM–5 µM, Selleckchem). DMSO (Nacalai Tesque) was added to a final concentration of 0.01% (volume/volume) to wells without drugs. Ten microliters of PrestoBlue cell viability reagent (Thermo Fisher Scientific) was added to each well 144 h after exposure to these drugs, and fluorescence intensity was measured with a 2030 ARVO X3 microplate reader and PerkinElmer 2030 Software v4.0 (PerkinElmer) (excitation; 530 nm, emission; 590 nm)<sup><a href="#CR55" class="usa-link" aria-describedby="CR55">55</a></sup>. Wells without cells were assessed as the negative controls, and survival data were graphically analyzed as a sigmoid curve by GraphPad Prism software v8.02 for Mac (GraphPad Software, Inc.).</p></section><section id="Sec19"><h3 class="pmc_sec_title">MANO-B method</h3>
<p id="Par47">The original MANO method is a high-throughput functional assay previously reported by our laboratory<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>,<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. Individually established DLD1 <em>BRCA2</em> (−/−) cells with stable <em>BRCA2</em> expression were mixed equally and cultured competitively. Cells were seeded at a density of 1 × 10<sup>4</sup> cells/cm<sup>2</sup> on day 0. During the 12-day treatment with PARP inhibitors (olaparib, niraparib, and rucaparib), CBDCA or DMSO, cells were passaged once, on day 6. On day 12, genomic DNA was isolated from cell lysates with a QIAamp DNA Mini Kit (Qiagen). Barcode sequences were amplified by PCR using 300 ng of genomic DNA (100,000-genome and 500,000-barcode equivalent, by the weight of 6 pg of genomic DNA per cell and an average copy number of integrated cDNA of 10 copies per cell) and primers containing index sequences for deep sequencing (Supplementary Table <a href="#MOESM1" class="usa-link">2</a>). The quantity and quality of the obtained libraries were evaluated using a Qubit 2.0 fluorometer (Thermo Fisher Scientific) and an Agilent 2200 TapeStation system. Libraries were deep sequenced on the MiSeq sequencer and MiSeq Control Software v2.5.0.5 using a Reagent Kit V2 (300 cycles), and the number of each barcode in each variant was counted. Variants were tested in at least two independent batches in technical triplicate. In every experiment, the wild-type and the D2723H variant were included as the benign and pathogenic controls, respectively. In each independent batch, cells were transfected with the plasmids independently on each occasion because transfection efficiency has a large impact on genomic integration and gene expression, which could affect the result of the MANO-B method. A single clone of each plasmid harboring each desired variant was used for all batches. To remove the concern that a plasmid harbored an additional undesired mutation, we had the entire sequence of each plasmid checked (including the vector backbone) rather than using two independent clones. In batch #1, 107 variants and one empty vector were evaluated. In batches #2 and #3, 244 variants and one empty vector were evaluated. The specific variants are shown in Supplementary Data <a href="#MOESM4" class="usa-link">1</a> and <a href="#MOESM6" class="usa-link">3</a>.</p></section><section id="Sec20"><h3 class="pmc_sec_title">Model assessment</h3>
<p id="Par48">The expectation–maximization algorithm was used to determine the appropriate Gaussian mixture model for the data from the MANO-B method with the mclust v5.4.5 package for the R language<sup><a href="#CR56" class="usa-link" aria-describedby="CR56">56</a></sup>. The model with the highest Bayesian information criterion was adopted.</p></section><section id="Sec21"><h3 class="pmc_sec_title">Bayesian hierarchical model analysis</h3>
<p id="Par49">Barcode counts obtained by the MANO-B method were analyzed using a Bayesian hierarchical mixed model for variant function, which was a modified version of the VarCall model, as previously described<sup><a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. The fold change in the barcode count for variants treated with each drug relative to that for variants treated with the DMSO control was calculated. These values were log normalized to the standard values of log<sub>10</sub>(1.0) for wild-type and log<sub>10</sub>(0.003) for D2723H as anchors. The remaining 242 variants were unlabeled for pathogenicity in this analysis. We hypothesized that the functional variant-specific effect <em>η</em><sub><em>v</em></sub> followed a 2-component Gaussian mixture distribution. The prior probability of the variants’ pathogenicity inside key domains was noninformative or based on the Align-GVGD classification obtained from the HCI Breast Cancer Genes Prior probabilities website (<a href="http://priors.hci.utah.edu/PRIORS" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://priors.hci.utah.edu/PRIORS</a>) and the BRCA Exchange website (<a href="https://brcaexchange.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://brcaexchange.org</a>). The Align-GVGD classification (C0–C65) was defined on the basis of evolutionary conservation of the protein sequence from <em>Strongylocentrotus purpuratus</em> to <em>Homo sapiens</em>. Key functional domains annotated by the HCI Breast Cancer Genes Prior probabilities website were as follows: the PALB2 interaction domain (amino acid residues 10–40), DNA-binding domain (2481–3186), and TR2 RAD51-binding domain (3269–3305). The prior probability outside key domains was estimated at 0.02 by the HCI and the BRCA Exchange, independent of the Align-GVGD classification.</p>
<p id="Par50">The equations and parameters of the model are as follows:</p>
<table class="disp-formula p" id="Equa"><tr><td class="formula"><math id="M2" display="block"><mspace width="2.0em"></mspace><mspace width="2.0em"></mspace><mspace width="2.0em"></mspace><mspace width="2.0em"></mspace><mspace width="2.0em"></mspace><munder><mrow><mo>∏</mo></mrow><mrow><mi>v</mi></mrow></munder><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mi mathvariant="normal">∣</mi><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><msub><mrow><mi>X</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><mi>θ</mi></mrow></mfenced><mo>=</mo><mspace width="2.0em"></mspace><mspace width="2.0em"></mspace><munder><mrow><mo>∏</mo></mrow><mrow><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>:</mo><mspace width="0.25em"></mspace><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">A</mi></mrow></mfenced></mrow></munder><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>∣</mo><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><msub><mrow><mi>X</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><mi>θ</mi></mrow></mfenced><munder><mrow><mo>∏</mo></mrow><mrow><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>:</mo><mspace width="0.25em"></mspace><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">N</mi></mrow></mfenced></mrow></munder><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mi mathvariant="normal">∣</mi><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">N</mi><mo>,</mo><msub><mrow><mi>X</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><mi>θ</mi></mrow></mfenced><munder><mrow><mo>∏</mo></mrow><mrow><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>:</mo><mspace width="0.25em"></mspace><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mspace width="0.25em"></mspace><mi mathvariant="normal">is</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">unknown</mi></mrow></mfenced></mrow></munder><mfenced close="]" open="[" separators=""><mrow><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi><mo>,</mo><mi mathvariant="normal">A</mi></mrow></mfenced></mrow></msub><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mi mathvariant="normal">∣</mi><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">A</mi><mo>,</mo><msub><mrow><mi>X</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><mi>θ</mi></mrow></mfenced><mo>+</mo><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi><mo>,</mo><mi mathvariant="normal">N</mi></mrow></mfenced></mrow></msub><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mi mathvariant="normal">∣</mi><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">N</mi><mo>,</mo><msub><mrow><mi>X</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><mi>θ</mi></mrow></mfenced></mrow></mfenced></math></td></tr></table>
<p id="Par51">The terms in the equation above are addressed below.</p>
<table class="disp-formula p" id="Equb"><tr><td class="formula"><math id="M4" display="block"><mi mathvariant="normal">Pr(Data</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">∣Parameters) :</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">likelihood</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">of</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">data</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">observation</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">with</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">parameters</mi><mspace width="0.16em"></mspace><mspace width="0.16em"></mspace><mspace width="0.16em"></mspace><mspace width="2.0em"></mspace><mi>v</mi><mo>:</mo><mi mathvariant="normal">variant</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">index</mi><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>:</mo><mi mathvariant="normal">measurements</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">of</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">functional</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">experiments</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">for</mi><mspace width="0.25em"></mspace><mi>v</mi><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>:</mo><mfenced close="" open="{" separators=""><mrow><mtable><mtr><mtd columnalign="center"><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi>A</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi><mi mathvariant="normal">= abnormal</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="center"><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi>N</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi><mo>=</mo><mi mathvariant="normal">normal</mi></mrow></mfenced></mtd></mtr></mtable></mrow></mfenced><msub><mrow><mi>X</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>:</mo><mi mathvariant="normal">batch</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">and</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">experimental</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">indices</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">for</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">each</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">measurement</mi><mi>θ</mi><mo>:</mo><mi mathvariant="normal">model</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">parameters</mi><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi><mo>,</mo><mi mathvariant="normal">A</mi><mo>/</mo><mi mathvariant="normal">N</mi></mrow></mfenced></mrow></msub><mo>:</mo><mi mathvariant="normal">prior</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">probability</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">that</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">is</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">abnormal</mi><mo>/</mo><mi mathvariant="normal">normal</mi></math></td></tr></table>
<p id="Par52">The true distributions of the data and parameters were estimated by the formula below.</p>
<p id="Par53">
<span xmlns:mml="http://www.w3.org/1998/Math/MathML" id="IEq1"><math id="M6"><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><msup><mrow><mi>v</mi></mrow><mrow><mo>*</mo></mrow></msup></mrow></msub><mi mathvariant="normal">∣</mi><msub><mrow><mi>D</mi></mrow><mrow><msup><mrow><mi>v</mi></mrow><mrow><mo>*</mo></mrow></msup></mrow></msub><mo>,</mo><msub><mrow><mi>X</mi></mrow><mrow><msup><mrow><mi>v</mi></mrow><mrow><mo>*</mo></mrow></msup></mrow></msub><mo>,</mo><mi>θ</mi></mrow></mfenced><mo>=</mo><munder><mrow><mo>∏</mo></mrow><mrow><mfenced close="}" open="{" separators=""><mrow><mfenced close=")" open="(" separators=""><mrow><mi>v</mi><mo>,</mo><mi>b</mi><mo>,</mo><mi>e</mi></mrow></mfenced><mo>:</mo><mi>v</mi><mo>=</mo><msup><mrow><mi>v</mi></mrow><mrow><mo>*</mo></mrow></msup></mrow></mfenced></mrow></munder><mi mathvariant="normal">Pr</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub><mi mathvariant="normal">∣</mi><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><mi>b</mi><mo>,</mo><mi>e</mi><mo>,</mo><mi>θ</mi></mrow></mfenced></math></span>
</p>
<p id="Par54">We established some constraints and weakly informative prior distributions as described below.</p>
<p id="Par55"><em>b</em>: batch index;</p>
<p id="Par56"><em>e</em>: experimental index;</p>
<p id="Par57"><em>β</em><sub>b</sub>: batch-specific random intercept effect;</p>
<p id="Par58"><em>τ</em><sub>b</sub>: batch-specific random slope effect;</p>
<p id="Par59"><em>κ</em><sub>1</sub>: center of the distribution <em>β</em><sub><em>b</em></sub>;</p>
<p id="Par60"><em>κ</em><sub>2</sub>: center of the distribution <em>τ</em><sub><em>b</em></sub>;</p>
<p id="Par61"><em>λ</em><sub>1</sub>: standard deviation of the distribution <em>β</em><sub><em>b</em></sub>;</p>
<p id="Par62"><em>λ</em><sub>2</sub>: standard deviation of the distribution <em>τ</em><sub><em>b</em></sub>;</p>
<p id="Par63"><em>η</em><sub><em>v</em></sub>: variant-specific random effect;</p>
<p id="Par64"><em>η</em><sub>abn</sub>: center of the abnormal variants’ <em>η</em><sub><em>v</em></sub> distribution;</p>
<p id="Par65"><em>η</em><sub><em>nor</em></sub>: center of the normal variants’ <em>η</em><sub><em>v</em></sub> distribution;</p>
<p id="Par66"><em>κ</em><sub>1</sub>: standard deviation of the abnormal variants’ <em>η</em><sub><em>v</em></sub> distribution;</p>
<p id="Par67"><em>κ</em><sub>2</sub>: standard deviation of the normal variants’ <em>η</em><sub><em>v</em></sub> distribution;</p>
<p id="Par68"><em>ψ</em>: residual error</p>
<table class="disp-formula p" id="Equi"><tr><td class="formula"><math id="M8" display="block"><mi mathvariant="normal">Key</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domains</mi><mo>:</mo><mfenced close="" open="{" separators=""><mrow><mtable><mtr><mtd columnalign="center"><mi mathvariant="normal">PALB2</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">interaction</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domain</mi><mspace width="0.25em"></mspace><mrow><mo>(</mo><mrow><mi mathvariant="normal">amino</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">acid</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">residues</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">10</mi><mo>−</mo><mi mathvariant="normal">40</mi></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="center"><mi mathvariant="normal">DNA</mi><mo>−</mo><mi mathvariant="normal">binding</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domain</mi><mspace width="0.25em"></mspace><mrow><mo>(</mo><mrow><mi mathvariant="normal">2481</mi><mo>−</mo><mi mathvariant="normal">3186</mi></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="center"><mi mathvariant="normal">TR2</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">RAD</mi><mi mathvariant="normal">51</mi><mo>−</mo><mi mathvariant="normal">binding</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domain</mi><mspace width="0.25em"></mspace><mrow><mo>(</mo><mrow><mi mathvariant="normal">3269</mi><mo>−</mo><mi mathvariant="normal">3305</mi></mrow><mo>)</mo></mrow></mtd></mtr></mtable></mrow></mfenced></math></td></tr></table>
<p id="Par69">The terms in the formulae above are addressed below.</p>
<table class="disp-formula p" id="Equj"><tr><td class="formula"><math id="M10" display="block"><mspace width="1.0em"></mspace><mspace width="0.16em"></mspace><mtable><mtr><mtd columnalign="left"><msub><mrow><mi>f</mi></mrow><mrow><mi>v</mi></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mrow><mo>(</mo><mrow><msub><mrow><mi>β</mi></mrow><mrow><mi>b</mi></mrow></msub><mo>+</mo><msub><mrow><mi>τ</mi></mrow><mrow><mi>b</mi></mrow></msub><msub><mrow><mi>η</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>,</mo><msub><mrow><mi>τ</mi></mrow><mrow><mi>b</mi></mrow></msub><mi>ψ</mi></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>β</mi></mrow><mrow><mi>b</mi></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mrow><mo>(</mo><mrow><msub><mrow><mi>κ</mi></mrow><mrow><mn>1</mn></mrow></msub><mo>,</mo><msub><mrow><mi>λ</mi></mrow><mrow><mn>1</mn></mrow></msub></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>τ</mi></mrow><mrow><mi>b</mi></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>κ</mi></mrow><mrow><mn>2</mn></mrow></msub><mo>,</mo><msub><mrow><mi>λ</mi></mrow><mrow><mn>2</mn></mrow></msub></mrow></mfenced><mo>,</mo><msub><mrow><mi>τ</mi></mrow><mrow><mi>b</mi></mrow></msub><mo>&gt;</mo><mn>0</mn></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>∣</mo><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">A</mi></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">abn</mi></mrow></msub><mo>,</mo><msub><mrow><mi>σ</mi></mrow><mrow><mn>1</mn></mrow></msub></mrow></mfenced><mrow><mo>{</mo><mrow><mi>v</mi><mo>:</mo><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">A</mi><mo>∧</mo><mi>v</mi><mo>≠</mo><mi mathvariant="normal"> D</mi><mn>2723</mn><mi mathvariant="normal">H</mi></mrow><mo>}</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>∣</mo><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">N</mi></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">nor</mi></mrow></msub><mo>,</mo><msub><mrow><mi>σ</mi></mrow><mrow><mn>2</mn></mrow></msub></mrow></mfenced><mrow><mo>{</mo><mrow><mi>v</mi><mo>:</mo><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mo>=</mo><mi mathvariant="normal">N</mi><mo>∧</mo><mi>v</mi><mo>≠</mo><mi mathvariant="normal"> WT</mi></mrow><mo>}</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">WT</mi></mrow></msub></mtd><mtd columnalign="left"><mo>=</mo></mtd><mtd columnalign="left"><msub><mrow><mi>log</mi></mrow><mrow><mn>10</mn></mrow></msub><mfenced close=")" open="(" separators=""><mrow><mn>1.0</mn></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">D</mi><mn>2723</mn><mi mathvariant="normal">H</mi></mrow></msub></mtd><mtd columnalign="left"><mo>=</mo></mtd><mtd columnalign="left"><msub><mrow><mi>log</mi></mrow><mrow><mn>10</mn></mrow></msub><mfenced close=")" open="(" separators=""><mrow><mn>0.003</mn></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">nor</mi></mrow></msub></mtd><mtd columnalign="left"><mo>=</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">estimated</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">value</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">by</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">mclust</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">package</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">with</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">the</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">training</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">data</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">set</mi></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">abn</mi></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">D</mi><mn>2723</mn><mi mathvariant="normal">H</mi></mrow></msub><mo>,</mo><mn>5</mn></mrow></mfenced><mrow><mo>(</mo><mrow><mi mathvariant="normal">training</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">data</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">set</mi></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">abn</mi></mrow></msub></mtd><mtd columnalign="left"><mo>=</mo></mtd><mtd columnalign="left"><mi>a</mi><mi>s</mi><mspace width="0.25em"></mspace><msub><mrow><mi>β</mi></mrow><mrow><mi>b</mi></mrow></msub><mo>+</mo><msub><mrow><mi>τ</mi></mrow><mrow><mi>b</mi></mrow></msub><msub><mrow><mi>η</mi></mrow><mrow><mi mathvariant="normal">abn</mi></mrow></msub><mspace width="0.25em"></mspace><mi mathvariant="normal">value</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">is</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">the</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">same</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">in</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">the</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">training</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">data</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">set</mi><mrow><mo>(</mo><mrow><mi mathvariant="normal">full</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">analysis</mi></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>κ</mi></mrow><mrow><mn>1</mn></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mrow><mo>(</mo><mrow><mn>0</mn><mo>,</mo><mn>5</mn></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>κ</mi></mrow><mrow><mn>2</mn></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Normal</mi><mrow><mo>(</mo><mrow><mn>1</mn><mo>,</mo><mn>5</mn></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><mi>ψ</mi><mo>,</mo><msub><mrow><mi>σ</mi></mrow><mrow><mn>1</mn></mrow></msub><mo>,</mo><msub><mrow><mi>σ</mi></mrow><mrow><mn>2</mn></mrow></msub><mo>,</mo><msub><mrow><mi>λ</mi></mrow><mrow><mn>1</mn></mrow></msub><mo>,</mo><msub><mrow><mi>λ</mi></mrow><mrow><mn>2</mn></mrow></msub></mtd><mtd columnalign="left"><mover accent="true"><mrow><mo>~</mo></mrow><mrow><mi>i</mi><mi>i</mi><mi>d</mi></mrow></mover></mtd><mtd columnalign="left"><mi mathvariant="normal">HalfNormal</mi><mrow><mo>(</mo><mrow><mn>0</mn><mo>,</mo><mn>5</mn></mrow><mo>)</mo></mrow></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi mathvariant="normal">Bernoulli</mi><mfenced close=")" open="(" separators=""><mrow><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>:</mo><msub><mrow><mi>D</mi></mrow><mrow><mi>v</mi></mrow></msub><mspace width="0.25em"></mspace><mi mathvariant="normal">is</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">unknown</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>1</mn><mo>,</mo><mn>1</mn></mrow></mfenced><mfenced close=")" open="(" separators=""><mrow><mi mathvariant="normal">noninformative</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">prior</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">probability</mi></mrow></mfenced></mtd></mtr></mtable><mspace width="2.0em"></mspace><mspace width="2.0em"></mspace><mspace width="0.16em"></mspace><mspace width="0.25em"></mspace><mfenced close="" open="{" separators=""><mrow><mtable><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>15.00</mn><mo>,</mo><mn>3.48</mn></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>∈</mo><mi mathvariant="normal">C</mi><mn>65</mn><mo>,</mo><mi mathvariant="normal">inside</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">key</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domains</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>5.38</mn><mo>,</mo><mn>2.57</mn></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>∈</mo><mi mathvariant="normal">C</mi><mn>35</mn><mo>,</mo><mi mathvariant="normal">C</mi><mn>45</mn><mo>,</mo><mi mathvariant="normal">C</mi><mn>55</mn><mo>,</mo><mi mathvariant="normal">inside</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">key</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domains</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>3.76</mn><mo>,</mo><mn>9.00</mn></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>∈</mo><mi mathvariant="normal">C</mi><mn>15</mn><mo>,</mo><mi mathvariant="normal">C</mi><mn>25</mn><mo>,</mo><mi mathvariant="normal">inside</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">key</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domains</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>1.43</mn><mo>,</mo><mn>73.1</mn></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>∈</mo><mi mathvariant="normal">C</mi><mn>0</mn><mo>,</mo><mi mathvariant="normal">inside</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">key</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domains</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>1.64</mn><mo>,</mo><mn>120.44</mn></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>∈</mo><mi mathvariant="normal">outside</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">key</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">domains</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><msub><mrow><mi>π</mi></mrow><mrow><mi mathvariant="normal">a</mi><mfenced close=")" open="(" separators=""><mrow><mi>v</mi></mrow></mfenced></mrow></msub></mtd><mtd columnalign="left"><mo>~</mo></mtd><mtd columnalign="left"><mi>B</mi><mi>e</mi><mi>t</mi><mi>a</mi><mfenced close=")" open="(" separators=""><mrow><mn>387</mn><mo>,</mo><mn>1.07</mn></mrow></mfenced><mfenced close="}" open="{" separators=""><mrow><mi>v</mi><mo>∈</mo><mi mathvariant="normal">nonsense</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">variants</mi></mrow></mfenced></mtd></mtr><mtr><mtd columnalign="left"><mspace width="0.25em"></mspace></mtd><mtd columnalign="left"><mspace width="0.25em"></mspace></mtd><mtd columnalign="left"><mrow><mo>(</mo><mrow><mi mathvariant="normal">Align</mi><mo>−</mo><mi mathvariant="normal">GVGD</mi><mo>−</mo><mi mathvariant="normal">based</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">prior</mi><mspace width="0.25em"></mspace><mi mathvariant="normal">probability</mi></mrow><mo>)</mo></mrow></mtd></mtr></mtable></mrow></mfenced></math></td></tr></table>
<p id="Par70">In the above model, the fixed value <em>η</em><sub>nor</sub> was arbitrarily estimated by the mclust v5.4.5 package with the training set data. In the full analysis, <em>η</em><sub>abn</sub> was fixed such that the value of <em>β</em><sub><em>b</em></sub> + <em>τ</em><sub><em>b</em></sub><em>η</em><sub>abn</sub> was the same as that in the training data set. Normal(<em>μ</em>,<em>σ</em>) denotes the normal distribution with mean <em>μ</em> and standard deviation <em>σ</em>; <em>X</em> ~ HalfNormal(0,5) indicates that <em>X</em> is normally distributed with a mean of 0 and a standard deviation of 5 but is constrained to be nonnegative. The parameters of the Beta distributions were determined such that their 2.5th and 97.5th percentiles fit the upper and lower 95% confidence limits of the Align-GVGD prediction for each class<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. The ranges of the normal distributions for the parameters’ prior distributions were set to adequately exceed the range of values expected for those parameters. The half-Cauchy distribution was thought to be superior to other weakly informative prior distributions for variance component parameters<sup><a href="#CR57" class="usa-link" aria-describedby="CR57">57</a></sup>, but the Cauchy distribution might be too broad for our model because very large values could not occur. Thus, a half-normal distribution was adopted for variance component parameters.</p></section><section id="Sec22"><h3 class="pmc_sec_title">Inference</h3>
<p id="Par71">A Hamiltonian Monte Carlo algorithm was used to perform inference for the above model. The source code written in the R<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup> v3.5.3 and Stan<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a></sup> v2.19.3 languages is available (<a href="https://github.com/MANO-B/Bayes" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/MANO-B/Bayes</a>). We ran four chains of samplers, including 1500 warmup iterations followed by 3500 sampling iterations, and every sampling iteration was adopted. The chain passed the Gelman and Rubin’s convergence diagnostic, as the <em>R</em>-hat values were less than 1.1 for all parameters<sup><a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>, indicating convergence across the four chains initiated from disparate starting values, and the simulated posterior values were drawn from the true posterior for each parameter. The marginal posterior means and credible intervals (CIs) of the model parameters, the BF and posterior probabilities of the pathogenic categories for each variant were calculated.</p></section><section id="Sec23"><h3 class="pmc_sec_title">Posterior predictive checks</h3>
<p id="Par72">To validate the model’s correctness, the fitness of estimation to observed data from 244 variants was statistically checked. QQ plots of the posterior expected standardized residuals of the log-normalized relative viability were generated using the car v3.0.6 package for the R language<sup><a href="#CR61" class="usa-link" aria-describedby="CR61">61</a></sup>. Simultaneous 95% CIs are plotted as green dotted lines. To confirm the match between the posterior predictive distribution of <em>f</em><sub><em>v</em></sub> and the observed data, we randomly drew 512 parameter samples from the trace. Then, we generated 612 random values per variant from a normal distribution specified by the values of <em>η</em>, <em>β</em>, <em>τ</em>, and <em>ψ</em> for each sample, accounting for the batch-to-batch ratio. A posterior predictive density curve of the log-normalized relative viability data was computed from 612 generated data sets containing 512 samples each.</p></section><section id="Sec24"><h3 class="pmc_sec_title">HDR assay</h3>
<p id="Par73">Twenty-four <em>BRCA2</em> variants encoded individually in the piggyBac vector and an I-SceI expression vector, pCBASce, were cotransfected into DLD1 <em>BRCA2</em> (−/−) cells harboring the DRGFP sequence, according to a previous report<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a>,<a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup>. Twenty-four hours before transfection, cells were seeded in 12-well plates at a density of 1 × 10<sup>5</sup> cells/well. Prior to transfection, the culture medium was replaced with 1 ml of fresh medium. The transfection mixture for individual wells was composed of 1 µg of the <em>BRCA2</em> expression vector, 500 ng of the pCBASce vector, 4 µl of Lipofectamine Stem Transfection Reagent, and 250 µl of Opti-MEM I Reduced Serum Medium. The transfection mixture was added to each well after 20 min of incubation at room temperature. I-SceI-induced DNA double-strand breaks in the DRGFP sequence were subsequently repaired by homologous recombination, and intact GFP-expressing cells were produced. Four days after transfection, cells were collected, and GFP-positive cells were counted by fluorescence-activated cell sorting (FACS) using a BD FACSCanto II and BD FACSDiva Software v6.1.3 (BD Bioscience). Every cell count was normalized and rescaled relative to a 1:5 ratio of D2723H:wild-type. All variants were analyzed in biological duplicate and technical triplicate.</p></section><section id="Sec25"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par74">All analyses were performed via the R language. The data are the means ± SD, means ± SEM, or means ± 95% CI, as stated in the figure legends. Exact binomial confidence limits were calculated for test sensitivity and specificity. Differences between variants were determined by the two-sided Kruskal–Wallis rank sum test. <em>p</em> &lt; 0.05 was considered statistically significant.</p></section><section id="Sec01"><h3 class="pmc_sec_title">Reporting summary</h3>
<p id="Par02">Further information on research design is available in the <a href="#MOESM10" class="usa-link">Nature Research Reporting Summary</a> linked to this article.</p></section></section><section id="sec27"><h2 class="pmc_sec_title">Supplementary information</h2>
<section id="Sec26"><section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (20.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Peer Review File</a><sup> (160.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM3"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">41467_2020_16141_MOESM3_ESM.pdf</a><sup> (5.8KB, pdf) </sup><p>Description of Additional Supplementary Files</p>
</div></div></section><section class="sm xbox font-sm" id="MOESM4"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 1</a><sup> (22.1KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM5"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM5_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 2</a><sup> (25.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM6"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM6_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 3</a><sup> (37.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM7"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM7_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 4</a><sup> (286.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM8"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 5</a><sup> (75.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM9"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM9_ESM.zip" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Software 1</a><sup> (265.8KB, zip) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM10"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM10_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (191.9KB, pdf) </sup>
</div></div></section></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>The authors thank A. Maruyama for technical assistance and N. Tanabe and T. Yoshida for collecting data. This study was supported by the World-leading Innovative Graduate Study Program for Life Science and Technology, The University of Tokyo, as part of the WISE Program (Doctoral Program for World-leading Innovative &amp; Smart Education), MEXT, Japan; JSPS KAKENHI grants (#19J13207); grants from the Program for Integrated Database of Clinical and Genomic Information under Grant Number JP18kk0205003, the Leading Advanced Projects for Medical Innovation (LEAP) under Grant Number JP18am0001001, and the Practical Research for Innovative Cancer Control under Grant Number JP18ck0106252 from the Japan Agency for Medical Research and Development, AMED; a grant for Endowed Department (Department of Medical Genomics, Graduate School of Medicine, The University of Tokyo) from Eisai Co., Ltd.</p></section><section id="App1" class="app"><section id="Sec27"><h3 class="pmc_sec_title">Source data</h3>
<div class="media p" id="MOESM11"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM11_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Source Data</a><sup> (24.2MB, xlsx) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>S.K. and H.M. conceived the project and designed the study. M.I., S.K., and H.M. developed the methodology. M.I. and S.I. performed experiments. M.I. and T.U. analyzed and interpreted the data. Y.M., K.T., A.S., and N.H. provided administrative, technical, or material support. H.K. and S.T. provided experimental and analytical support. M.I., S.K., and H.M. wrote and edited the manuscript with feedback from all authors.</p></section><section id="notes2"><h2 class="pmc_sec_title">Data availability</h2>
<p>The source data underlying Figs. <a href="#Fig2" class="usa-link">2</a> and <a href="#Fig3" class="usa-link">3d</a>, and Supplementary Figs. <a href="#MOESM1" class="usa-link">1a–c</a>, <a href="#MOESM1" class="usa-link">2</a>, <a href="#MOESM1" class="usa-link">3</a>, <a href="#MOESM1" class="usa-link">7</a>–<a href="#MOESM1" class="usa-link">9</a>, and <a href="#MOESM1" class="usa-link">11a</a> are provided as a <a href="#MOESM11" class="usa-link">Source Data</a> file. All the raw data that support the findings of this study have been deposited in <a href="https://github.com/MANO-B/Bayes" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/MANO-B/Bayes</a>.</p></section><section id="notes3"><h2 class="pmc_sec_title">Code availability</h2>
<p>All codes that support the findings of this study are provided as <a href="#MOESM9" class="usa-link">Supplementary Software</a> and available from <a href="https://github.com/MANO-B/Bayes" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/MANO-B/Bayes</a>.</p></section><section id="FPar1"><h2 class="pmc_sec_title">Competing interests</h2>
<p id="Par75">The authors declare no competing interests.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm">
<div class="fn p" id="fn1"><p><strong>Peer review information</strong>
<em>Nature Communications</em> thanks the anonymous reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.</p></div>
<div class="fn p" id="fn2"><p><strong>Publisher’s note</strong> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div>
</div></section><section id="_ci93_" lang="en" class="contrib-info"><h2 class="pmc_sec_title">Contributor Information</h2>
<p>Shinji Kohsaka, Email: skohsaka@ncc.go.jp.</p>
<p>Hiroyuki Mano, Email: hmano@ncc.go.jp.</p></section><section id="sec30"><h2 class="pmc_sec_title">Supplementary information</h2>
<p><strong>Supplementary information</strong> is available for this paper at 10.1038/s41467-020-16141-8.</p></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Wooster R, Weber BL. Breast and ovarian cancer. N. Engl. J. Med. 2003;348:2339–2347. doi: 10.1056/NEJMra012284.</cite> [<a href="https://doi.org/10.1056/NEJMra012284" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12788999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N.%20Engl.%20J.%20Med.&amp;title=Breast%20and%20ovarian%20cancer&amp;author=R%20Wooster&amp;author=BL%20Weber&amp;volume=348&amp;publication_year=2003&amp;pages=2339-2347&amp;pmid=12788999&amp;doi=10.1056/NEJMra012284&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Finch AP, et al.  Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation. J. Clin. Oncol. 2014;32:1547–1553. doi: 10.1200/JCO.2013.53.2820.</cite> [<a href="https://doi.org/10.1200/JCO.2013.53.2820" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4026578/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24567435/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Oncol.&amp;title=Impact%20of%20oophorectomy%20on%20cancer%20incidence%20and%20mortality%20in%20women%20with%20a%20BRCA1%20or%20BRCA2%20mutation&amp;author=AP%20Finch&amp;volume=32&amp;publication_year=2014&amp;pages=1547-1553&amp;pmid=24567435&amp;doi=10.1200/JCO.2013.53.2820&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Heemskerk-Gerritsen BA, et al.  Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic. Ann. Surg. Oncol. 2007;14:3335–3344. doi: 10.1245/s10434-007-9449-x.</cite> [<a href="https://doi.org/10.1245/s10434-007-9449-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2077910/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17541692/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Surg.%20Oncol.&amp;title=Prophylactic%20mastectomy%20in%20BRCA1/2%20mutation%20carriers%20and%20women%20at%20risk%20of%20hereditary%20breast%20cancer:%20long-term%20experiences%20at%20the%20Rotterdam%20Family%20Cancer%20Clinic&amp;author=BA%20Heemskerk-Gerritsen&amp;volume=14&amp;publication_year=2007&amp;pages=3335-3344&amp;pmid=17541692&amp;doi=10.1245/s10434-007-9449-x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Paluch-Shimon S, et al.  Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening. Ann. Oncol. 2016;27:v103–v110. doi: 10.1093/annonc/mdw327.</cite> [<a href="https://doi.org/10.1093/annonc/mdw327" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27664246/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=Prevention%20and%20screening%20in%20BRCA%20mutation%20carriers%20and%20other%20breast/ovarian%20hereditary%20cancer%20syndromes:%20ESMO%20Clinical%20Practice%20Guidelines%20for%20cancer%20prevention%20and%20screening&amp;author=S%20Paluch-Shimon&amp;volume=27&amp;publication_year=2016&amp;pages=v103-v110&amp;pmid=27664246&amp;doi=10.1093/annonc/mdw327&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Farmer H, et al.  Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature. 2005;434:917–921. doi: 10.1038/nature03445.</cite> [<a href="https://doi.org/10.1038/nature03445" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Targeting%20the%20DNA%20repair%20defect%20in%20BRCA%20mutant%20cells%20as%20a%20therapeutic%20strategy&amp;author=H%20Farmer&amp;volume=434&amp;publication_year=2005&amp;pages=917-921&amp;pmid=15829967&amp;doi=10.1038/nature03445&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Bryant HE, et al.  Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature. 2005;434:913–917. doi: 10.1038/nature03443.</cite> [<a href="https://doi.org/10.1038/nature03443" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15829966/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Specific%20killing%20of%20BRCA2-deficient%20tumours%20with%20inhibitors%20of%20poly(ADP-ribose)%20polymerase&amp;author=HE%20Bryant&amp;volume=434&amp;publication_year=2005&amp;pages=913-917&amp;pmid=15829966&amp;doi=10.1038/nature03443&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Richards S, et al.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 2015;17:405–424. doi: 10.1038/gim.2015.30.</cite> [<a href="https://doi.org/10.1038/gim.2015.30" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4544753/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25741868/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Standards%20and%20guidelines%20for%20the%20interpretation%20of%20sequence%20variants:%20a%20joint%20consensus%20recommendation%20of%20the%20American%20College%20of%20Medical%20Genetics%20and%20Genomics%20and%20the%20Association%20for%20Molecular%20Pathology&amp;author=S%20Richards&amp;volume=17&amp;publication_year=2015&amp;pages=405-424&amp;pmid=25741868&amp;doi=10.1038/gim.2015.30&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Plon SE, et al.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum. Mutat. 2008;29:1282–1291. doi: 10.1002/humu.20880.</cite> [<a href="https://doi.org/10.1002/humu.20880" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3075918/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Sequence%20variant%20classification%20and%20reporting:%20recommendations%20for%20improving%20the%20interpretation%20of%20cancer%20susceptibility%20genetic%20test%20results&amp;author=SE%20Plon&amp;volume=29&amp;publication_year=2008&amp;pages=1282-1291&amp;pmid=18951446&amp;doi=10.1002/humu.20880&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Tavtigian SV, Greenblatt MS, Goldgar DE, Boffetta P, Group IUGVW.  Assessing pathogenicity: overview of results from the IARC Unclassified Genetic Variants Working Group. Hum. Mutat. 2008;29:1261–1264. doi: 10.1002/humu.20903.</cite> [<a href="https://doi.org/10.1002/humu.20903" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2966307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951436/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Assessing%20pathogenicity:%20overview%20of%20results%20from%20the%20IARC%20Unclassified%20Genetic%20Variants%20Working%20Group&amp;author=SV%20Tavtigian&amp;author=MS%20Greenblatt&amp;author=DE%20Goldgar&amp;author=P%20Boffetta&amp;volume=29&amp;publication_year=2008&amp;pages=1261-1264&amp;pmid=18951436&amp;doi=10.1002/humu.20903&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Easton DF, et al.  A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am. J. Hum. Genet. 2007;81:873–883. doi: 10.1086/521032.</cite> [<a href="https://doi.org/10.1086/521032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2265654/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17924331/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20systematic%20genetic%20assessment%20of%201,433%20sequence%20variants%20of%20unknown%20clinical%20significance%20in%20the%20BRCA1%20and%20BRCA2%20breast%20cancer-predisposition%20genes&amp;author=DF%20Easton&amp;volume=81&amp;publication_year=2007&amp;pages=873-883&amp;pmid=17924331&amp;doi=10.1086/521032&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Lindor NM, et al.  A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS) Hum. Mutat. 2012;33:8–21. doi: 10.1002/humu.21627.</cite> [<a href="https://doi.org/10.1002/humu.21627" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3242438/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21990134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=A%20review%20of%20a%20multifactorial%20probability-based%20model%20for%20classification%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20(VUS)&amp;author=NM%20Lindor&amp;volume=33&amp;publication_year=2012&amp;pages=8-21&amp;pmid=21990134&amp;doi=10.1002/humu.21627&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Momozawa Y, et al.  Germline pathogenic variants of 11 breast cancer genes in 7,051 Japanese patients and 11,241 controls. Nat. Commun. 2018;9:4083. doi: 10.1038/s41467-018-06581-8.</cite> [<a href="https://doi.org/10.1038/s41467-018-06581-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6172276/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30287823/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Germline%20pathogenic%20variants%20of%2011%20breast%20cancer%20genes%20in%207,051%20Japanese%20patients%20and%2011,241%20controls&amp;author=Y%20Momozawa&amp;volume=9&amp;publication_year=2018&amp;pages=4083&amp;pmid=30287823&amp;doi=10.1038/s41467-018-06581-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Ernst C, et al.  Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics. BMC Med. Genomics. 2018;11:35. doi: 10.1186/s12920-018-0353-y.</cite> [<a href="https://doi.org/10.1186/s12920-018-0353-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5870501/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29580235/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Med.%20Genomics&amp;title=Performance%20of%20in%20silico%20prediction%20tools%20for%20the%20classification%20of%20rare%20BRCA1/2%20missense%20variants%20in%20clinical%20diagnostics&amp;author=C%20Ernst&amp;volume=11&amp;publication_year=2018&amp;pages=35&amp;pmid=29580235&amp;doi=10.1186/s12920-018-0353-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Brnich SE, et al.  Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework. Genome Med. 2019;12:3. doi: 10.1186/s13073-019-0690-2.</cite> [<a href="https://doi.org/10.1186/s13073-019-0690-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6938631/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31892348/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genome%20Med.&amp;title=Recommendations%20for%20application%20of%20the%20functional%20evidence%20PS3/BS3%20criterion%20using%20the%20ACMG/AMP%20sequence%20variant%20interpretation%20framework&amp;author=SE%20Brnich&amp;volume=12&amp;publication_year=2019&amp;pages=3&amp;pmid=31892348&amp;doi=10.1186/s13073-019-0690-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Toland AE, Andreassen PR. DNA repair-related functional assays for the classification of BRCA1 and BRCA2 variants: a critical review and needs assessment. J. Med. Genet. 2017;54:721–731. doi: 10.1136/jmedgenet-2017-104707.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2017-104707" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28866612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=DNA%20repair-related%20functional%20assays%20for%20the%20classification%20of%20BRCA1%20and%20BRCA2%20variants:%20a%20critical%20review%20and%20needs%20assessment&amp;author=AE%20Toland&amp;author=PR%20Andreassen&amp;volume=54&amp;publication_year=2017&amp;pages=721-731&amp;pmid=28866612&amp;doi=10.1136/jmedgenet-2017-104707&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Findlay GM, et al.  Accurate classification of BRCA1 variants with saturation genome editing. Nature. 2018;562:217–222. doi: 10.1038/s41586-018-0461-z.</cite> [<a href="https://doi.org/10.1038/s41586-018-0461-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6181777/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30209399/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Accurate%20classification%20of%20BRCA1%20variants%20with%20saturation%20genome%20editing&amp;author=GM%20Findlay&amp;volume=562&amp;publication_year=2018&amp;pages=217-222&amp;pmid=30209399&amp;doi=10.1038/s41586-018-0461-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Starita LM, et al.  Massively parallel functional analysis of BRCA1 RING domain variants. Genetics. 2015;200:413–422. doi: 10.1534/genetics.115.175802.</cite> [<a href="https://doi.org/10.1534/genetics.115.175802" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4492368/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25823446/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genetics&amp;title=Massively%20parallel%20functional%20analysis%20of%20BRCA1%20RING%20domain%20variants&amp;author=LM%20Starita&amp;volume=200&amp;publication_year=2015&amp;pages=413-422&amp;pmid=25823446&amp;doi=10.1534/genetics.115.175802&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Starita LM, et al.  A multiplex homology-directed DNA repair assay reveals the impact of more than 1,000 BRCA1 missense substitution variants on protein function. Am. J. Hum. Genet. 2018;103:498–508. doi: 10.1016/j.ajhg.2018.07.016.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2018.07.016" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6174279/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30219179/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=A%20multiplex%20homology-directed%20DNA%20repair%20assay%20reveals%20the%20impact%20of%20more%20than%201,000%20BRCA1%20missense%20substitution%20variants%20on%20protein%20function&amp;author=LM%20Starita&amp;volume=103&amp;publication_year=2018&amp;pages=498-508&amp;pmid=30219179&amp;doi=10.1016/j.ajhg.2018.07.016&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Guidugli L, et al.  Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches. Am. J. Hum. Genet. 2018;102:233–248. doi: 10.1016/j.ajhg.2017.12.013.</cite> [<a href="https://doi.org/10.1016/j.ajhg.2017.12.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5985401/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29394989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Am.%20J.%20Hum.%20Genet.&amp;title=Assessment%20of%20the%20clinical%20relevance%20of%20BRCA2%20missense%20variants%20by%20functional%20and%20computational%20approaches&amp;author=L%20Guidugli&amp;volume=102&amp;publication_year=2018&amp;pages=233-248&amp;pmid=29394989&amp;doi=10.1016/j.ajhg.2017.12.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Hart SN, et al.  Comprehensive annotation of BRCA1 and BRCA2 missense variants by functionally validated sequence-based computational prediction models. Genet. Med. 2019;21:71–80. doi: 10.1038/s41436-018-0018-4.</cite> [<a href="https://doi.org/10.1038/s41436-018-0018-4" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6287763/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29884841/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Comprehensive%20annotation%20of%20BRCA1%20and%20BRCA2%20missense%20variants%20by%20functionally%20validated%20sequence-based%20computational%20prediction%20models&amp;author=SN%20Hart&amp;volume=21&amp;publication_year=2019&amp;pages=71-80&amp;pmid=29884841&amp;doi=10.1038/s41436-018-0018-4&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Guidugli L, et al.  Functional assays for analysis of variants of uncertain significance in BRCA2. Hum. Mutat. 2014;35:151–164. doi: 10.1002/humu.22478.</cite> [<a href="https://doi.org/10.1002/humu.22478" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3995136/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24323938/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Functional%20assays%20for%20analysis%20of%20variants%20of%20uncertain%20significance%20in%20BRCA2&amp;author=L%20Guidugli&amp;volume=35&amp;publication_year=2014&amp;pages=151-164&amp;pmid=24323938&amp;doi=10.1002/humu.22478&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Ding S, et al.  Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice. Cell. 2005;122:473–483. doi: 10.1016/j.cell.2005.07.013.</cite> [<a href="https://doi.org/10.1016/j.cell.2005.07.013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16096065/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Efficient%20transposition%20of%20the%20piggyBac%20(PB)%20transposon%20in%20mammalian%20cells%20and%20mice&amp;author=S%20Ding&amp;volume=122&amp;publication_year=2005&amp;pages=473-483&amp;pmid=16096065&amp;doi=10.1016/j.cell.2005.07.013&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Hucl T, et al.  A syngeneic variance library for functional annotation of human variation: application to BRCA2. Cancer Res. 2008;68:5023–5030. doi: 10.1158/0008-5472.CAN-07-6189.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-6189" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2536704/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18593900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=A%20syngeneic%20variance%20library%20for%20functional%20annotation%20of%20human%20variation:%20application%20to%20BRCA2&amp;author=T%20Hucl&amp;volume=68&amp;publication_year=2008&amp;pages=5023-5030&amp;pmid=18593900&amp;doi=10.1158/0008-5472.CAN-07-6189&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Drean A, et al.  Modeling therapy resistance in BRCA1/2-mutant cancers. Mol. Cancer Ther. 2017;16:2022–2034. doi: 10.1158/1535-7163.MCT-17-0098.</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-17-0098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6157714/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28619759/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cancer%20Ther.&amp;title=Modeling%20therapy%20resistance%20in%20BRCA1/2-mutant%20cancers&amp;author=A%20Drean&amp;volume=16&amp;publication_year=2017&amp;pages=2022-2034&amp;pmid=28619759&amp;doi=10.1158/1535-7163.MCT-17-0098&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Cline MS, et al.  BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2. PLoS Genet. 2018;14:e1007752. doi: 10.1371/journal.pgen.1007752.</cite> [<a href="https://doi.org/10.1371/journal.pgen.1007752" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6324924/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30586411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20Genet.&amp;title=BRCA%20Challenge:%20BRCA%20Exchange%20as%20a%20global%20resource%20for%20variants%20in%20BRCA1%20and%20BRCA2&amp;author=MS%20Cline&amp;volume=14&amp;publication_year=2018&amp;pages=e1007752&amp;pmid=30586411&amp;doi=10.1371/journal.pgen.1007752&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Parsons MT, et al.  Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: an ENIGMA resource to support clinical variant classification. Hum. Mutat. 2019;40:1557–1578. doi: 10.1002/humu.23818.</cite> [<a href="https://doi.org/10.1002/humu.23818" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6772163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31131967/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Large%20scale%20multifactorial%20likelihood%20quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20variants:%20an%20ENIGMA%20resource%20to%20support%20clinical%20variant%20classification&amp;author=MT%20Parsons&amp;volume=40&amp;publication_year=2019&amp;pages=1557-1578&amp;pmid=31131967&amp;doi=10.1002/humu.23818&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Lee JS, et al.  Reclassification of BRCA1 and BRCA2 variants of uncertain significance: a multifactorial analysis of multicentre prospective cohort. J. Med. Genet. 2018;55:794–802. doi: 10.1136/jmedgenet-2018-105565.</cite> [<a href="https://doi.org/10.1136/jmedgenet-2018-105565" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30415210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Med.%20Genet.&amp;title=Reclassification%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance:%20a%20multifactorial%20analysis%20of%20multicentre%20prospective%20cohort&amp;author=JS%20Lee&amp;volume=55&amp;publication_year=2018&amp;pages=794-802&amp;pmid=30415210&amp;doi=10.1136/jmedgenet-2018-105565&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Yusa K, Zhou L, Li MA, Bradley A, Craig NL. A hyperactive piggyBac transposase for mammalian applications. Proc. Natl. Acad. Sci. USA. 2011;108:1531–1536. doi: 10.1073/pnas.1008322108.</cite> [<a href="https://doi.org/10.1073/pnas.1008322108" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3029773/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21205896/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=A%20hyperactive%20piggyBac%20transposase%20for%20mammalian%20applications&amp;author=K%20Yusa&amp;author=L%20Zhou&amp;author=MA%20Li&amp;author=A%20Bradley&amp;author=NL%20Craig&amp;volume=108&amp;publication_year=2011&amp;pages=1531-1536&amp;pmid=21205896&amp;doi=10.1073/pnas.1008322108&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Kohsaka S, et al.  A method of high-throughput functional evaluation of EGFR gene variants of unknown significance in cancer. Sci. Transl. Med. 2017;9:eaan6566. doi: 10.1126/scitranslmed.aan6566.</cite> [<a href="https://doi.org/10.1126/scitranslmed.aan6566" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29141884/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Transl.%20Med.&amp;title=A%20method%20of%20high-throughput%20functional%20evaluation%20of%20EGFR%20gene%20variants%20of%20unknown%20significance%20in%20cancer&amp;author=S%20Kohsaka&amp;volume=9&amp;publication_year=2017&amp;pages=eaan6566&amp;pmid=29141884&amp;doi=10.1126/scitranslmed.aan6566&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Nagano M, et al.  High-throughput functional evaluation of variants of unknown significance in ERBB2. Clin. Cancer Res. 2018;24:5112–5122. doi: 10.1158/1078-0432.CCR-18-0991.</cite> [<a href="https://doi.org/10.1158/1078-0432.CCR-18-0991" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29967253/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin.%20Cancer%20Res.&amp;title=High-throughput%20functional%20evaluation%20of%20variants%20of%20unknown%20significance%20in%20ERBB2&amp;author=M%20Nagano&amp;volume=24&amp;publication_year=2018&amp;pages=5112-5122&amp;pmid=29967253&amp;doi=10.1158/1078-0432.CCR-18-0991&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Wu K, et al.  Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res. 2005;65:417–426.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/15695382/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Functional%20evaluation%20and%20cancer%20risk%20assessment%20of%20BRCA2%20unclassified%20variants&amp;author=K%20Wu&amp;volume=65&amp;publication_year=2005&amp;pages=417-426&amp;pmid=15695382&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Farrugia DJ, et al.  Functional assays for classification of BRCA2 variants of uncertain significance. Cancer Res. 2008;68:3523–3531. doi: 10.1158/0008-5472.CAN-07-1587.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-07-1587" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2936780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18451181/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=Functional%20assays%20for%20classification%20of%20BRCA2%20variants%20of%20uncertain%20significance&amp;author=DJ%20Farrugia&amp;volume=68&amp;publication_year=2008&amp;pages=3523-3531&amp;pmid=18451181&amp;doi=10.1158/0008-5472.CAN-07-1587&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Guidugli L, et al.  A classification model for BRCA2 DNA binding domain missense variants based on homology-directed repair activity. Cancer Res. 2013;73:265–275. doi: 10.1158/0008-5472.CAN-12-2081.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-12-2081" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3537884/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23108138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=A%20classification%20model%20for%20BRCA2%20DNA%20binding%20domain%20missense%20variants%20based%20on%20homology-directed%20repair%20activity&amp;author=L%20Guidugli&amp;volume=73&amp;publication_year=2013&amp;pages=265-275&amp;pmid=23108138&amp;doi=10.1158/0008-5472.CAN-12-2081&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>So MK, et al.  Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines. Breast Cancer. 2019;26:510–519. doi: 10.1007/s12282-019-00951-w.</cite> [<a href="https://doi.org/10.1007/s12282-019-00951-w" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30725392/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer&amp;title=Reinterpretation%20of%20BRCA1%20and%20BRCA2%20variants%20of%20uncertain%20significance%20in%20patients%20with%20hereditary%20breast/ovarian%20cancer%20using%20the%20ACMG/AMP%202015%20guidelines&amp;author=MK%20So&amp;volume=26&amp;publication_year=2019&amp;pages=510-519&amp;pmid=30725392&amp;doi=10.1007/s12282-019-00951-w&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Woods N, et al.  Functional assays provide a robust tool for the clinical annotation of genetic variants of uncertain significance. npj Genome Med. 2016;1:16001. doi: 10.1038/npjgenmed.2016.1.</cite> [<a href="https://doi.org/10.1038/npjgenmed.2016.1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5539989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28781887/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=npj%20Genome%20Med.&amp;title=Functional%20assays%20provide%20a%20robust%20tool%20for%20the%20clinical%20annotation%20of%20genetic%20variants%20of%20uncertain%20significance&amp;author=N%20Woods&amp;volume=1&amp;publication_year=2016&amp;pages=16001&amp;pmid=28781887&amp;doi=10.1038/npjgenmed.2016.1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Iversen ES, Jr., Couch FJ, Goldgar DE, Tavtigian SV, Monteiro AN. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1. Cancer Epidemiol. Biomark. Prev. 2011;20:1078–1088. doi: 10.1158/1055-9965.EPI-10-1214.</cite> [<a href="https://doi.org/10.1158/1055-9965.EPI-10-1214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3111818/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21447777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Epidemiol.%20Biomark.%20Prev.&amp;title=A%20computational%20method%20to%20classify%20variants%20of%20uncertain%20significance%20using%20functional%20assay%20data%20with%20application%20to%20BRCA1&amp;author=ES%20Iversen&amp;author=FJ%20Couch&amp;author=DE%20Goldgar&amp;author=SV%20Tavtigian&amp;author=AN%20Monteiro&amp;volume=20&amp;publication_year=2011&amp;pages=1078-1088&amp;pmid=21447777&amp;doi=10.1158/1055-9965.EPI-10-1214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Tavtigian SV, et al.  Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet. Med. 2018;20:1054–1060. doi: 10.1038/gim.2017.210.</cite> [<a href="https://doi.org/10.1038/gim.2017.210" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6336098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29300386/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Modeling%20the%20ACMG/AMP%20variant%20classification%20guidelines%20as%20a%20Bayesian%20classification%20framework&amp;author=SV%20Tavtigian&amp;volume=20&amp;publication_year=2018&amp;pages=1054-1060&amp;pmid=29300386&amp;doi=10.1038/gim.2017.210&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Xia B, et al.  Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. Mol. Cell. 2006;22:719–729. doi: 10.1016/j.molcel.2006.05.022.</cite> [<a href="https://doi.org/10.1016/j.molcel.2006.05.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16793542/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol.%20Cell&amp;title=Control%20of%20BRCA2%20cellular%20and%20clinical%20functions%20by%20a%20nuclear%20partner,%20PALB2&amp;author=B%20Xia&amp;volume=22&amp;publication_year=2006&amp;pages=719-729&amp;pmid=16793542&amp;doi=10.1016/j.molcel.2006.05.022&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Zhang J, Fujiwara Y, Yamamoto S, Shibuya H. A meiosis-specific BRCA2 binding protein recruits recombinases to DNA double-strand breaks to ensure homologous recombination. Nat. Commun. 2019;10:722. doi: 10.1038/s41467-019-08676-2.</cite> [<a href="https://doi.org/10.1038/s41467-019-08676-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6374363/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30760716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=A%20meiosis-specific%20BRCA2%20binding%20protein%20recruits%20recombinases%20to%20DNA%20double-strand%20breaks%20to%20ensure%20homologous%20recombination&amp;author=J%20Zhang&amp;author=Y%20Fujiwara&amp;author=S%20Yamamoto&amp;author=H%20Shibuya&amp;volume=10&amp;publication_year=2019&amp;pages=722&amp;pmid=30760716&amp;doi=10.1038/s41467-019-08676-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A. Classification of rare missense substitutions, using risk surfaces, with genetic- and molecular-epidemiology applications. Hum. Mutat. 2008;29:1342–1354. doi: 10.1002/humu.20896.</cite> [<a href="https://doi.org/10.1002/humu.20896" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3938023/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18951461/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Classification%20of%20rare%20missense%20substitutions,%20using%20risk%20surfaces,%20with%20genetic-%20and%20molecular-epidemiology%20applications&amp;author=SV%20Tavtigian&amp;author=GB%20Byrnes&amp;author=DE%20Goldgar&amp;author=A%20Thomas&amp;volume=29&amp;publication_year=2008&amp;pages=1342-1354&amp;pmid=18951461&amp;doi=10.1002/humu.20896&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Esashi F, et al.  CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair. Nature. 2005;434:598–604. doi: 10.1038/nature03404.</cite> [<a href="https://doi.org/10.1038/nature03404" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15800615/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=CDK-dependent%20phosphorylation%20of%20BRCA2%20as%20a%20regulatory%20mechanism%20for%20recombinational%20repair&amp;author=F%20Esashi&amp;volume=434&amp;publication_year=2005&amp;pages=598-604&amp;pmid=15800615&amp;doi=10.1038/nature03404&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Farber-Katz S, et al.  Quantitative analysis of BRCA1 and BRCA2 germline splicing variants using a novel RNA-massively parallel sequencing assay. Front. Oncol. 2018;8:286. doi: 10.3389/fonc.2018.00286.</cite> [<a href="https://doi.org/10.3389/fonc.2018.00286" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6072868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30101128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front.%20Oncol.&amp;title=Quantitative%20analysis%20of%20BRCA1%20and%20BRCA2%20germline%20splicing%20variants%20using%20a%20novel%20RNA-massively%20parallel%20sequencing%20assay&amp;author=S%20Farber-Katz&amp;volume=8&amp;publication_year=2018&amp;pages=286&amp;pmid=30101128&amp;doi=10.3389/fonc.2018.00286&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Balia C, Galli A, Caligo MA. Effect of the overexpression of BRCA2 unclassified missense variants on spontaneous homologous recombination in human cells. Breast Cancer Res. Treat. 2011;129:1001–1009. doi: 10.1007/s10549-011-1607-y.</cite> [<a href="https://doi.org/10.1007/s10549-011-1607-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21671020/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.%20Treat.&amp;title=Effect%20of%20the%20overexpression%20of%20BRCA2%20unclassified%20missense%20variants%20on%20spontaneous%20homologous%20recombination%20in%20human%20cells&amp;author=C%20Balia&amp;author=A%20Galli&amp;author=MA%20Caligo&amp;volume=129&amp;publication_year=2011&amp;pages=1001-1009&amp;pmid=21671020&amp;doi=10.1007/s10549-011-1607-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Shimelis H, et al.  BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Res. 2017;77:2789–2799. doi: 10.1158/0008-5472.CAN-16-2568.</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-16-2568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5508554/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28283652/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res.&amp;title=BRCA2%20hypomorphic%20missense%20variants%20confer%20moderate%20risks%20of%20breast%20cancer&amp;author=H%20Shimelis&amp;volume=77&amp;publication_year=2017&amp;pages=2789-2799&amp;pmid=28283652&amp;doi=10.1158/0008-5472.CAN-16-2568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Bradbury AR, et al.  Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers. Genet. Med. 2008;10:161–166. doi: 10.1097/GIM.0b013e318163487d.</cite> [<a href="https://doi.org/10.1097/GIM.0b013e318163487d" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4199586/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18344704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Genet.%20Med.&amp;title=Uptake%20and%20timing%20of%20bilateral%20prophylactic%20salpingo-oophorectomy%20among%20BRCA1%20and%20BRCA2%20mutation%20carriers&amp;author=AR%20Bradbury&amp;volume=10&amp;publication_year=2008&amp;pages=161-166&amp;pmid=18344704&amp;doi=10.1097/GIM.0b013e318163487d&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Lim D, Ngeow J. Evaluation of the methods to identify patients who may benefit from PARP inhibitor use. Endocr. Relat. Cancer. 2016;23:R267–R285. doi: 10.1530/ERC-16-0116.</cite> [<a href="https://doi.org/10.1530/ERC-16-0116" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27226207/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr.%20Relat.%20Cancer&amp;title=Evaluation%20of%20the%20methods%20to%20identify%20patients%20who%20may%20benefit%20from%20PARP%20inhibitor%20use&amp;author=D%20Lim&amp;author=J%20Ngeow&amp;volume=23&amp;publication_year=2016&amp;pages=R267-R285&amp;pmid=27226207&amp;doi=10.1530/ERC-16-0116&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Davies H, et al.  HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures. Nat. Med. 2017;23:517–525. doi: 10.1038/nm.4292.</cite> [<a href="https://doi.org/10.1038/nm.4292" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5833945/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28288110/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Med.&amp;title=HRDetect%20is%20a%20predictor%20of%20BRCA1%20and%20BRCA2%20deficiency%20based%20on%20mutational%20signatures&amp;author=H%20Davies&amp;volume=23&amp;publication_year=2017&amp;pages=517-525&amp;pmid=28288110&amp;doi=10.1038/nm.4292&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Nones K, et al.  Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers. Ann. Oncol. 2019;30:1071–1079. doi: 10.1093/annonc/mdz132.</cite> [<a href="https://doi.org/10.1093/annonc/mdz132" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6637375/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31090900/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann.%20Oncol.&amp;title=Whole-genome%20sequencing%20reveals%20clinically%20relevant%20insights%20into%20the%20aetiology%20of%20familial%20breast%20cancers&amp;author=K%20Nones&amp;volume=30&amp;publication_year=2019&amp;pages=1071-1079&amp;pmid=31090900&amp;doi=10.1093/annonc/mdz132&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Daniels MJ, Wang Y, Lee M, Venkitaraman AR. Abnormal cytokinesis in cells deficient in the breast cancer susceptibility protein BRCA2. Science. 2004;306:876–879. doi: 10.1126/science.1102574.</cite> [<a href="https://doi.org/10.1126/science.1102574" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15375219/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Abnormal%20cytokinesis%20in%20cells%20deficient%20in%20the%20breast%20cancer%20susceptibility%20protein%20BRCA2&amp;author=MJ%20Daniels&amp;author=Y%20Wang&amp;author=M%20Lee&amp;author=AR%20Venkitaraman&amp;volume=306&amp;publication_year=2004&amp;pages=876-879&amp;pmid=15375219&amp;doi=10.1126/science.1102574&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Shivji MKK, Renaudin X, Williams CH, Venkitaraman AR. BRCA2 regulates transcription elongation by RNA polymerase II to prevent R-loop accumulation. Cell Rep. 2018;22:1031–1039. doi: 10.1016/j.celrep.2017.12.086.</cite> [<a href="https://doi.org/10.1016/j.celrep.2017.12.086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5846855/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29386125/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Rep.&amp;title=BRCA2%20regulates%20transcription%20elongation%20by%20RNA%20polymerase%20II%20to%20prevent%20R-loop%20accumulation&amp;author=MKK%20Shivji&amp;author=X%20Renaudin&amp;author=CH%20Williams&amp;author=AR%20Venkitaraman&amp;volume=22&amp;publication_year=2018&amp;pages=1031-1039&amp;pmid=29386125&amp;doi=10.1016/j.celrep.2017.12.086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Leman R, et al.  Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort. Nucleic Acids Res. 2018;46:7913–7923. doi: 10.1093/nar/gky372.</cite> [<a href="https://doi.org/10.1093/nar/gky372" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6125621/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29750258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res.&amp;title=Novel%20diagnostic%20tool%20for%20prediction%20of%20variant%20spliceogenicity%20derived%20from%20a%20set%20of%20395%20combined%20in%20silico/in%20vitro%20studies:%20an%20international%20collaborative%20effort&amp;author=R%20Leman&amp;volume=46&amp;publication_year=2018&amp;pages=7913-7923&amp;pmid=29750258&amp;doi=10.1093/nar/gky372&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Acedo A, Hernandez-Moro C, Curiel-Garcia A, Diez-Gomez B, Velasco EA. Functional classification of BRCA2 DNA variants by splicing assays in a large minigene with 9 exons. Hum. Mutat. 2015;36:210–221. doi: 10.1002/humu.22725.</cite> [<a href="https://doi.org/10.1002/humu.22725" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4371643/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25382762/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Functional%20classification%20of%20BRCA2%20DNA%20variants%20by%20splicing%20assays%20in%20a%20large%20minigene%20with%209%20exons&amp;author=A%20Acedo&amp;author=C%20Hernandez-Moro&amp;author=A%20Curiel-Garcia&amp;author=B%20Diez-Gomez&amp;author=EA%20Velasco&amp;volume=36&amp;publication_year=2015&amp;pages=210-221&amp;pmid=25382762&amp;doi=10.1002/humu.22725&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Acedo A, et al.  Comprehensive splicing functional analysis of DNA variants of the BRCA2 gene by hybrid minigenes. Breast Cancer Res. 2012;14:R87. doi: 10.1186/bcr3202.</cite> [<a href="https://doi.org/10.1186/bcr3202" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3446350/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22632462/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res.&amp;title=Comprehensive%20splicing%20functional%20analysis%20of%20DNA%20variants%20of%20the%20BRCA2%20gene%20by%20hybrid%20minigenes&amp;author=A%20Acedo&amp;volume=14&amp;publication_year=2012&amp;pages=R87&amp;pmid=22632462&amp;doi=10.1186/bcr3202&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Oh M, et al.  BRCA1 and BRCA2 gene mutations and colorectal cancer risk: systematic review and meta-analysis. J. Natl. Cancer Inst. 2018;110:1178–1189. doi: 10.1093/jnci/djy148.</cite> [<a href="https://doi.org/10.1093/jnci/djy148" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30380096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Natl.%20Cancer%20Inst.&amp;title=BRCA1%20and%20BRCA2%20gene%20mutations%20and%20colorectal%20cancer%20risk:%20systematic%20review%20and%20meta-analysis&amp;author=M%20Oh&amp;volume=110&amp;publication_year=2018&amp;pages=1178-1189&amp;pmid=30380096&amp;doi=10.1093/jnci/djy148&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR55">
<span class="label">55.</span><cite>Lall N, Henley-Smith CJ, De Canha MN, Oosthuizen CB, Berrington D. Viability reagent, PrestoBlue, in comparison with other available reagents, utilized in cytotoxicity and antimicrobial assays. Int. J. Microbiol. 2013;2013:420601. doi: 10.1155/2013/420601.</cite> [<a href="https://doi.org/10.1155/2013/420601" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3638707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23653650/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Microbiol.&amp;title=Viability%20reagent,%20PrestoBlue,%20in%20comparison%20with%20other%20available%20reagents,%20utilized%20in%20cytotoxicity%20and%20antimicrobial%20assays&amp;author=N%20Lall&amp;author=CJ%20Henley-Smith&amp;author=MN%20De%20Canha&amp;author=CB%20Oosthuizen&amp;author=D%20Berrington&amp;volume=2013&amp;publication_year=2013&amp;pages=420601&amp;pmid=23653650&amp;doi=10.1155/2013/420601&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Scrucca L, Fop M, Murphy TB, Raftery AE. mclust 5: clustering, classification and density estimation using Gaussian finite mixture models. R J. 2016;8:289–317.</cite> [<a href="/articles/PMC5096736/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27818791/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=R%20J.&amp;title=mclust%205:%20clustering,%20classification%20and%20density%20estimation%20using%20Gaussian%20finite%20mixture%20models&amp;author=L%20Scrucca&amp;author=M%20Fop&amp;author=TB%20Murphy&amp;author=AE%20Raftery&amp;volume=8&amp;publication_year=2016&amp;pages=289-317&amp;pmid=27818791&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Gelman A. Prior distributions for variance parameters in hierarchical models. Bayesian Anal. 2006;1:515–534.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Bayesian%20Anal.&amp;title=Prior%20distributions%20for%20variance%20parameters%20in%20hierarchical%20models&amp;author=A%20Gelman&amp;volume=1&amp;publication_year=2006&amp;pages=515-534&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Ihaka R, Gentleman R. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 1996;5:299–314.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Graph.%20Stat.&amp;title=R:%20a%20language%20for%20data%20analysis%20and%20graphics&amp;author=R%20Ihaka&amp;author=R%20Gentleman&amp;volume=5&amp;publication_year=1996&amp;pages=299-314&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Gelman A, Lee D, Guo J. Stan: a probabilistic programming language for Bayesian inference and optimization. J. Educ. Behav. Stat. 2015;40:530–543.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Educ.%20Behav.%20Stat.&amp;title=Stan:%20a%20probabilistic%20programming%20language%20for%20Bayesian%20inference%20and%20optimization&amp;author=A%20Gelman&amp;author=D%20Lee&amp;author=J%20Guo&amp;volume=40&amp;publication_year=2015&amp;pages=530-543&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J. Comput. Graph. Stat. 1997;7:434–455.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Comput.%20Graph.%20Stat.&amp;title=General%20methods%20for%20monitoring%20convergence%20of%20iterative%20simulations&amp;author=SP%20Brooks&amp;author=A%20Gelman&amp;volume=7&amp;publication_year=1997&amp;pages=434-455&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR61">
<span class="label">61.</span><cite>Fox J, Weisberg S, An R.  Companion to Applied Regression. 2nd edn. Thousand Oaks: Sage Publications; 2011. </cite> [<a href="https://scholar.google.com/scholar_lookup?title=Companion%20to%20Applied%20Regression&amp;author=J%20Fox&amp;author=S%20Weisberg&amp;author=R%20An&amp;publication_year=2011&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Supplementary information</a><sup> (20.3MB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Peer Review File</a><sup> (160.2KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">41467_2020_16141_MOESM3_ESM.pdf</a><sup> (5.8KB, pdf) </sup><p>Description of Additional Supplementary Files</p>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM4_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 1</a><sup> (22.1KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material5_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM5_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 2</a><sup> (25.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material6_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM6_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 3</a><sup> (37.6KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material7_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM7_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 4</a><sup> (286.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material8_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM8_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Data 5</a><sup> (75.8KB, xlsx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material9_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM9_ESM.zip" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Software 1</a><sup> (265.8KB, zip) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material10_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/7244490/bin/41467_2020_16141_MOESM10_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Reporting Summary</a><sup> (191.9KB, pdf) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The source data underlying Figs. <a href="#Fig2" class="usa-link">2</a> and <a href="#Fig3" class="usa-link">3d</a>, and Supplementary Figs. <a href="#MOESM1" class="usa-link">1a–c</a>, <a href="#MOESM1" class="usa-link">2</a>, <a href="#MOESM1" class="usa-link">3</a>, <a href="#MOESM1" class="usa-link">7</a>–<a href="#MOESM1" class="usa-link">9</a>, and <a href="#MOESM1" class="usa-link">11a</a> are provided as a <a href="#MOESM11" class="usa-link">Source Data</a> file. All the raw data that support the findings of this study have been deposited in <a href="https://github.com/MANO-B/Bayes" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/MANO-B/Bayes</a>.</p>
<p>All codes that support the findings of this study are provided as <a href="#MOESM9" class="usa-link">Supplementary Software</a> and available from <a href="https://github.com/MANO-B/Bayes" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://github.com/MANO-B/Bayes</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nature Communications are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41467-020-16141-8"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41467_2020_Article_16141.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/7244490/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/7244490/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC7244490%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC7244490/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC7244490/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC7244490/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/32444794/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC7244490/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/32444794/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC7244490/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/7244490/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="7rSkFEhnMlMKDXEYwTOq1hZdZE1L4dfTJBixrwKV33g4O39ZMSc0ypST6wqY7YKo">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-574fdcc6.js"></script>
    
    

    </body>
</html>
